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ABSTRACT OF DISSERTATION 
 
 
 
 
CARDIAC RHYTHM DURING MECHANICAL VENTILATION 
AND WEANING FROM VENTILATION 
 
The transition from mechanical ventilation (MV) to spontaneous ventilation 
during weaning is associated with hemodynamic alterations and autonomic nervous 
system (ANS) alterations (reflected by heart rate variability [HRV]). Although cardiac 
dysrhythmias are an important manifestation of hemodynamic alterations, development 
of dysrhythmias during MV and weaning and subsequent impact on length of MV has 
received little attention. 
 
The purposes of this dissertation were to 1) evaluate the relationship of heart rate 
variability (HRV) during weaning to the development of cardiac dysrhythmias and 2) 
determine the relationship of cardiac dysrhythmias to length of MV.   
 
A convenience sample of 35 patients (66.7% men; mean age 53.3 years) who 
required MV was enrolled in this study.  Continuous 3-lead electrocardiographic data 
were collected for 24 hours at baseline during MV and for the first 2 hours during the 
initial weaning trial. HRV was evaluated using spectral power analysis. 
 
Twenty- seven patients out of 30 were exposed to a combination of pressure 
support (8-15 cm H2O) and continuous positive airway pressure 5 cm H2O during 
weaning trial. Three patients self- extubated and received supplemental oxygen through 
either a partial rebreathing or non-rebreathing mask. Low frequency (LF) power HRV 
decreased, while high frequency (HF) and very low frequency (VLF) power HRV did not 
change during weaning.  Multiple regression analyses showed that LF and HF HRV were 
significant predictors of occurrence of ventricular and supraventricular ectopic beats 
during weaning, while VLF power predicted occurrence of ventricular ectopic beats only. 
The mean of occurrence of supraventricular ectopic beats per hour during weaning was 
double the mean at baseline, while the mean of ventricular ectopic beats per hour did not 
change. Mean number of supraventricular ectopic beats per hour during weaning was a 
significant predictor of length of MV.  
 
This dissertation has fulfilled an important gap in the evidence base for cardiac 
dysrhythmias during weaning from MV. Cardiac dysrhythmias and HRV alterations 
 
 
should be systemically evaluated during MV and weaning trials in order to decrease 
length of MV. 
 
KEYWORDS: Cardiac Dysrhythmias, Mechanical Ventilation, Weaning, Heart Rate 
Variability, Length of Ventilation 
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CHAPTER I:  
CARDIAC RHYTHM DURING MECHANICAL VENTILATION AND WEANING 
FROM VENTILATION 
 
Significance of Problem 
Mechanical ventilation (MV), a well established intensive care unit (ICU) strategy, 
is used increasingly often to support pulmonary function in critically ill patients. 1, 2 In 
critical care units, as many as 90% of patients require MV.1, 3-5 Despite its lifesaving 
potential, MV is associated with a wide variety of risks including ventilator-associated 
pneumonia, barotrauma, cardiovascular compromise, and diaphragm fatigue.6, 7 
Prolonged MV increases the possibility of occurrence of these complications.7  
Reintubation following accidental or intentional premature extubation is also associated 
with high morbidity, mortality, health care costs, longer ICU and hospital stay, and a 
greater chance to transfer to a rehabilitation institution. 1, 8, 9 Thus, the goal for 
mechanically ventilated patients is to transition back to spontaneous ventilation as rapidly 
as feasible, a process called weaning.3 Liberation from MV may be easily achieved in 
most patients who require routine postoperative ventilator support or those with overdose 
of sedatives. However, weaning is often difficult and the chance of failure is higher in 
patients who have chronic pulmonary disease, heart failure, central nervous system 
dysfunction, renal failure, hepatic failure or sepsis. 8-10 
During weaning, different modes of spontaneous ventilation can be used that 
result in different hemodynamic responses that are dependent on intrathoracic pressure 
(ITP) changes inherent to each12, 13 and the individual’s underlying cardiac function. 12, 14, 
15 Unfortunately, about one third of mechanically ventilated patients exhibit significant 
difficulty weaning from MV 9, 16, 17 and consequently have a longer duration of MV and a 
longer hospital stay.  The Collective Task Force of the American College of Chest 
Physicians, the American Association for Respiratory Care, and the American College of 
Critical Care has identified weaning from MV as a research priority.18  
Multiple investigators have examined the impact of oxygenation failure, 
respiratory muscle dysfunction and cardiovascular dysfunction as major factors in 
weaning outcomes.19-28 Although dysrhythmias are an important manifestation of 
cardiovascular dysfunction, the development of dysrhythmias during weaning and 
subsequent impact on length of MV has received little attention.  
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The transition from MV to spontaneous ventilation during the weaning process 
can induce hemodynamic alterations 14, 29-32 as a result of changes in intrathoracic blood 
volume. Altered autonomic nervous system (ANS) response (reflected by decreased heart 
rate variability [HRV]) 33, 34  to hemodynamic alterations can cause dysrhythmias.35-45 
Dysrhythmias subsequently may increase the length of MV as suggested in the study 
proposed model (Figure 1). 
Model for Testing Hypotheses 
Changes in intrathoracic pressure (ITP) and lung volume that occur during 
weaning may induce significant hemodynamic changes that influence thoracic blood 
volume and flow.12, 27, 33 The autonomic nervous system responds to the hemodynamic 
alterations inherent to different weaning modes in order to maintain adequate cardiac 
output and oxygen delivery. Compensatory ANS alterations include changes in heart rate, 
ventricular afterload, contractility, and filling time. However, altered ANS tone (reflected 
by decreased HRV) in response to hemodynamic alterations during weaning could be 
arrhythmogenic 46 depending on the magnitude of hemodynamic alterations, underlying 
cardiovascular function, and the adequacy of compensatory mechanisms.7, 14, 15 Patients 
who develop cardiac dysrhythmias during weaning may have inadequate cardiac output 
and oxygen delivery required for metabolic needs and consequently fail weaning attempts.  
In this study, we hypothesized that there is a relationship between the occurrence 
of dysrhythmias during initial weaning attempt and length of MV (Figure 1.1). Patients 
with underlying cardiovascular dysfunction and impaired compensatory mechanisms for 
hemodynamic changes in response to weaning attempts may experience significant 
cardiac dysrhythmias.17 Patients with cardiac dysrhythmias may fail to wean from MV 
and require longer support from MV. 
Purpose of the Study 
The purposes of this study were to 1) evaluate the relationship HRV (as a 
noninvasive reflection of ANS tone) during weaning to the development of cardiac 
dysrhythmias and 2) determine the relationship of cardiac dysrhythmias during weaning 
to length of MV. Clinically significant cardiac dysrhythmias (i.e., ventricular ectopy, 
ventricular tachycardia/fibrillation, atrial fibrillation/flutter, and supraventricular 
tachycardia) were the focus of this study because of their potential negative consequences 
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in patients who are undergoing weaning trials. Studying and identifying cardiac 
dysrhythmias that occur during MV and weaning, and determining the role that 
dysrhythmias might play in length of MV are vital in order to provide appropriate care 
and management for mechanically ventilated patients. 
Specific Aims 
The specific aims of the study were the following: 
1: To determine the relationship of HRV (measured in the frequency domain) 
during weaning to the development of cardiac dysrhythmias after controlling for baseline 
HRV measured during MV. 
Hypothesis 1: HRV measured in the frequency domain during weaning will be 
related to the occurrence of cardiac dysrhythmias. That is, in patients with cardiac 
dysrhythmias during weaning compared to those without dysrhythmias, HRV will 
demonstrate higher power in the low frequency (0.04 to 0.15 Hz range) and very 
low frequency (< 0.04 Hz), and decreased power in the high frequency range 
(0.15 to 0.40 Hz). 
2: To determine the relationship of the occurrence of dysrhythmias during 
weaning to length of MV after controlling for Acute Physiology and Chronic Health 
Evaluation (APACHE) IV score.   
Hypothesis 2: Rate of dysrhythmias per hour during weaning will be an 
independent predictor of length of MV. 
 
Figure1.1: Conceptual model of the relationship between heart rate variability, 
dysrhythmias and length of ventilation 
  
 
 
 
 
 
 
 
 
Copyright© Muna Hassan Hammash 2010 
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CHAPTER II  
REVIEW OF LITERATURE 
 
Transition from MV to spontaneous ventilation during the weaning process 
produces hemodynamic alterations and autonomic nervous system (ANS) dysfunction 
(reflected by decreased HRV) especially in patients with underlying cardiovascular 
dysfunction. Autonomic nervous system alterations can cause cardiac dysrhythmias 
depending on underlying cardiovascular function and adequacy of compensatory 
mechanisms. Although dysrhythmias that develop during weaning are often clinically 
significant, there is paucity of research on expression of dysrhythmias during weaning 
and its impact on length of MV. 
Management of dysrhythmias that develop during weaning from MV is vital 
because dysrhythmias can induce myocardial ischemia, impair myocardial contractility 
and decrease cardiac index, eventually leading to weaning failure and longer time of MV. 
Prolonged MV is associated with a variety of risks and complications such as ventilator-
associated pneumonia, lung barotrauma, and cardiovascular compromise.6, 7 
The purpose of this chapter is to provide a physiological background of factors 
that contribute to occurrence of cardiac dysrhythmias during weaning. The focus is on 
physiology of cardiac action potential, underlying mechanisms of cardiac dysrhythmias, 
and physiology of HRV. Cardiovascular effects of mechanical ventilation and weaning; 
relationship between HRV to the development of cardiac dysrhythmias during weaning, 
process of weaning from MV, measurement of HRV are reviewed and presented in this 
chapter also.   
Heart- lung interaction during mechanical ventilation and weaning from ventilation 
Cardiac and pulmonary systems interact with each other during spontaneous and 
mechanical ventilation. This interaction involves mechanical, neural, and humoral 
mechanisms.14, 30, 47 Intrathoracic structures including the heart, pericardium, great 
vessels and veins are affected by changes in the surrounding pressure, which are the 
pleural pressure and ITP.14 Changes in pleural pressure, ITP, and lung volume associated 
with spontaneous ventilation and MV affect the determinants of stroke volume—preload, 
afterload and myocardial contractility. 14, 15, 32, 47-49  
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Cardiovascular effects of spontaneous ventilation. 
During spontaneous inspiration, negative ITP induces a decrease in right atrial 
pressure and an increase in RV transmural pressure (i.e., the difference between cardiac 
intramural and extramural pressure). The decrease in right atrial pressure and the increase 
in right ventricular (RV) transmural pressure subsequently increase the pressure gradient 
between vana cava and right atrium for venous return to the heart. The result of increased 
venous return to the right heart is an increase in intrathoracic vascular volume and RV 
diastolic filling volume.50 The increase in intrathoracic vascular volume and RV diastolic 
filling volume increases RV end- diastolic volume, which results in an increase in stroke 
volume by the Frank-Starling mechanism. Changes in left ventricular (LV) preload tend 
to follow RV preload within 1-2 beats.50  
An increase in RV end- diastolic volume results in a decrease in LV diastolic 
compliance and end-diastolic volume through ventricular interdependence and leftward 
septal shift.  LV afterload increases secondary to the increased LV transmural pressure. 
As a result, LV stroke volume decreases and a fall (<10mmHg) in systolic blood pressure 
during inspiration is observed. 51, 52  The decrease in systolic blood pressure stimulates 
the baroreceptor reflex, which consequently increases sympathetic outflow to the heart 
and a slight increase in heart rate occurs.  
In summary, negative ITP that occurs during spontaneous inspiration causes 
increased venous return, RV preload and LV afterload, leading to a small fall in systolic 
blood pressure and a slight increase in heart rate. 
Cardiovascular effects of mechanical ventilation. 
Unlike spontaneous breathing, positive pressure MV results in an increase in ITP 
during inspiration and throughout the respiratory cycle if positive end expiratory pressure 
(PEEP) or continuous positive airway pressure (CPAP) are used. 49  
During inspiration, positive ITP is associated with decreases in venous return and 
RV transmural pressure, causing a reduction in RVEDV (preload).53, 54 Also, positive ITP 
and expanding lung volume compress vena cava and RV, which in turn cause a reduction 
in RV preload.  At peak lung inflation, especially in severe obstructive pulmonary disease 
with lung hyperinflation, or when PEEP is applied, pulmonary vascular resistance (PVR) 
is elevated and RV ejection is impeded. 7, 55, 56 In critically ill patients (e.g., patients with 
 
6 
adult respiratory distress syndrome), increases in PVR may markedly increase RV 
afterload, and induce acute cor pulmonale and cardiovascular collapse secondary to 
excessive RV dilation, RV ischemia, and compromised LV filling. 56, 57  
Right ventricular output directly influences left atrial and LV filling volume and 
output. Decreased RV end- diastolic volume and RV ejection decrease pulmonary venous 
flow, LV end- diastolic volume,58 LV stroke volume, and cardiac output. Positive ITP 
reduces LV afterload by decreasing transmural LV systolic pressure.59  Reduction in LV 
afterload facilitates ventricular ejection and helps maintain cardiac output (CO), although 
sometimes at a lower level than normal, during MV.2 
Given the tendency toward a lower CO in some patients receiving MV and to 
increase blood pressure and maintain adequate cardiac output, the neurohormonal system 
responds to these hemodynamic alterations by secreting catecholamines, vasopressin and 
rennin. Activation of rennin- angiotensin system induces increases in angiotensin II and 
aldosterone levels. The result of increases of these neurohormones includes tachycardia, 
vasoconstriction, oliguria, and retention of sodium and water, and subsequently increases 
in blood pressure. An increase in heart rate occurs as an initial response to lower CO. 
This can be seen in the beat-to-beat variations in heart rate that compensate for cyclical 
differences in RV and LV output.  Lung inflation mediates these instantaneous 
cardiovascular alterations by modulating autonomic tone. The lungs are highly innervated 
with autonomic fibers.  Normally, lung inflation with tidal volume <10ml/kg induces 
vagal tone withdrawal and increases heart rate, producing the phenomenon of respiratory 
sinus arrhythmia. Lung inflation of >15ml/kg tidal volume induces both increased vagal 
tone and sympathetic withdrawal, which produces heart rate decreases.7  
In summary, positive ITP that is associated with positive pressure ventilation 
causes decreases in venous return, RV end- diastolic volume, and LV afterload. 
Decreases in preload and afterload cause a dramatic decrease in CO in patients with 
hypovolemia.60 Decreases in preload and afterload may improve CO and decrease oxygen 
demand in patients with hypervolemic heart failure, or impaired cardiac function. 
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Cardiovascular effects of weaning.  
 
Conceptually, "ventilator weaning" represents the period of transition from total 
ventilatory support to spontaneous breathing. 18, 61, 62 On average, weaning accounts for 
40% of the total duration of mechanically ventilatory support.3, 63  During ventilator 
weaning, different modes of spontaneous ventilation can be used that result in different 
hemodynamic responses dependent on ITP changes inherent to each. 12, 13 Up to one third 
of mechanically ventilated patients fail weaning trial.9, 16, 17 The hemodynamic responses 
to weaning include cardiovascular dysfunction, autonomic alteration, cardiac 
dysrhythmias, and myocardial ischemia. 
 
During weaning, ITP decreases.  The degree of ITP reduction depends on the 
mode used.  The decrease in ITP may result in abrupt increases in venous return, RV 
preload and LV afterload.  Also during weaning, hypoventilation and alveolar hypoxia 
may occur.  Hypoventilation and alveolar hypoxia induce hypoxic pulmonary 
vasoconstriction, profoundly increasing PVR, RV afterload64 and subsequently 
decreasing RV ejection.  Reduced RV ejection induces RV dilatation, decreases coronary 
blood flow, and shifts the interventricular septum to the left.  Increased LV afterload may 
impede LV ejection and result in increases in LV end-diastolic volume and pressure.  LV 
dilation, further increase in LV afterload, pulmonary edema secondary to acute heart 
failure, and coronary blood flow reduction may occur.  Alterations in preload and 
afterload that occur during weaning may induce acute cardiac mechanical changes and 
ANS alterations that may be arrhythmogenic.  
 
Acute ventricular loading (preload) or dilation that occurs during weaning plays 
an important role in the development of cardiac dysrhythmias.  Mechanical changes (i.e., 
cardiac chambers loading and stretch) have been shown to induce significant 
electrophysiological changes (i.e., shortening myocardial action potential and 
refractoriness) mediated by cardiac myocyte stretch-activated channels and selective-ion 
channels.65, 66  This mechano-electrical feedback mechanism induces atrial and 
ventricular dysrhythmias, predominantly ectopic beats, non-sustained ventricular 
tachycardia, and atrial dysrhythmias.  The risk of dysrhythmia development during 
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weaning is higher in patients with impaired ventricular function and congestive heart 
failure who have chronic regionally or globally impaired dilated hearts and are subject to 
pressure /volume overload.65-73  
Changes in ANS tone occur as a result of fluid shifts into the intrathoracic 
vascular compartment from changes in ITP.12, 27, 33 The ANS compensates for these fluid 
shifts by an increase in sympathetic tone and a decrease in parasympathetic tone. The 
result is a decrease in HRV and further increase in LV afterload. Sympathetic dominance 
is associated with negative effects on the cardiac myocyte action potential (i.e., decreased 
ventricular refractoriness, increased myocardial excitability) that may enhance abnormal 
automaticity, triggered activity and reentry mechanisms of cardiac dysrhythmias.  
Cardiac dysrhythmias may impair myocardial oxygen delivery and cardiac pumping, 
resulting in myocardial ischemia and low cardiac index. 
Myocardial ischemia results from an imbalance between oxygen supply and 
demand. During weaning, oxygen supply may be reduced by hypoxemia, inadequate 
coronary blood flow, and dysrhythmias. Pulmonary edema that may occur during 
weaning causes ventilation-perfusion mismatching as manifested by hypoxemia.  
Inadequate coronary blood flow is produced by ventricular dilation, and increased LV 
end-diastolic pressure and afterload.  Cardiac dysrhythmias, particularly ectopic beats, 
may limit diastolic filling time and oxygen supply and induce myocardial ischemia. 
Significant cardiac dysrhythmias and myocardial ischemia may cause ventricular 
hypokinesis or dyskinesis, which in turn decreases ejection fraction and results in low 
cardiac index. Weaning failure and increased mechanical ventilation time may result. 
Overall, patients with cardiovascular dysfunction and impaired compensatory 
mechanisms for alterations in right and left preload and afterload; and ANS that occur 
during weaning may experience significant cardiac dysrhythmias. Dysrhythmias can 
induce myocardial ischemia,19, 22, 25, 28, 74-76 impair myocardial contractility, 76  decrease 
ventricular ejection fraction and cardiac index, eventually leading to weaning failure and 
longer length of ventilation. 
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Cardiac Rhythm 
Normal cardiac rhythm. 
Heart rhythm, the normal occurrence of heart beats in regular intervals, is initiated 
by intrinsic electrical system composed of modified myocytes. These modified myocytes 
include the SA node, atrioventricular (AV) node, the bundle of His and Purkinjie 
fibers.77-79 
The depolarization of the heart is normally initiated by the SA node “the 
pacemaker of the heart”.79 The SA node is a cluster of specialized cells that generates the 
initial electrical impulse of each normal heart beat. Electrical impulses from the SA node 
stimulate adjacent cells and are transmitted through the atria to the AV node via 
conducting internodal tracts. The AV node slows conduction velocity and thus delays 
impulse transmission. Then, a specialized conduction pathway composed of Bundle of 
His and Purkinjie fibers conduct the wave of depolarization throughout the ventricles to 
initiate ventricular contraction.79  
The SA node is considered the pacemaker of the heart because it has the greatest 
rate of spontaneous firing. If the SA node fails to produce impulses, as seen in heart 
blocks, the tissue with the next highest automaticity rate, typically the AV node functions 
as the pacemaker. If the AV node fails to produce impulses, the Bundle of His may 
function as the pacemaker. However, the rate of depolarization of the Bundle of His is 
less than the rate of depolarization of the SA and AV nodes.77-80 
The SA node is innervated by both sympathetic and parasympathetic nerve fibers. 
At rest, parasympathetic fibers dominate and release acetylcholine that slows rate of 
depolarization of the SA node and maintains heart rate between 60 and 80 beats/min. 
During exercise, relative withdrawal of vagal tone and activation of sympathetic nerves 
occur. The sympathetic nerve fibers release norepinephrine that increases the SA node 
rate of depolarization resulting in increased in heart rate.78, 79, 81 In addition to the 
sympathetic and parasympathetic nervous system, the intrinsic rate of SA depolarization 
is modulated by baroreceptor activity, the intrinsic cardiac nervous system, 
cardiopulmonary reflexes, and respiration.  
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The phenomenon in which respiration modulates the SA node depolarization rate 
and cyclical variation stroke volume and consequently cardiac output is referred to as 
respiratory sinus arrhythmia (RSA). The negative ITP and positive intra-abdominal 
pressure that occur during spontaneous inspiration enhance RV filling and stroke volume. 
At the same time, lung expansion that occurs during inspiration causes pooling of blood 
in the pulmonary circulation and decreases the return of blood to the left ventricle. 
Consequently, LV stroke volume decreases transiently, vagal efferent stimuli are 
inhibited and heart rate increases. The reverse occurs during expiration,77 whereas 
efferent vagal is stimulated and heart rate decreases. 
Overall, withdrawal of vagal tone occurs during inspiration77 and results in the 
physiologic phenomenon called respiratory sinus arrhythmia, an observable manifestation 
of HRV that reflects the ability of the body to make beat-by-beat adjustments in cardiac 
output. 
Electrophysiology of cardiac excitation. 
Cardiac tissue is excitable and capable of responding to stimulation with a large, 
rapid shift in membrane voltage.77, 79, 80 Cyclical depolarization and repolarization of the 
cell in which changes of the membrane voltage occur is called an action potential.  The 
action potential lasts only for a few hundred milliseconds and triggers a sequence of 
organized myocardial contraction.77, 79, 80  
Physiology of action potential. 
The action potential consists of five phases: rapid upstroke (phase 0), early 
repolarization (phase1), a plateau (phase 2), repolarization (phase 3), and resting potential 
(phase 4). Phases of action potentials result from movement of sodium (Na+), Ca+2 and 
potassium (K+) ions across the cell membrane through various ion channels and exchange 
pumps.77, 79, 80 
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Resting membrane potential. 
The resting membrane potential (phase 4) is generated by differences in ion 
concentration across the cell membrane. Potassium ions are highly concentrated inside 
the cell; while Na+ is highly concentrated outside the cell membrane. At resting state, the 
cell membrane is highly permeable to K+ ions through the inward rectifier channel (iK ir). 
Sodium inward movement through the inward background current is very small 
compared to K+ movement. However, the resting membrane potential remains stable 
despite the continuous slow exchange of K+ for Na+.77, 79, 80 
Types of cardiac action potentials. 
There are two main types of cardiac action potentials: fast and slow response 
action potentials. The speed of conduction through tissue is a function of the slope and 
amplitude of phase 0. Fast-response action potential occur in the atrial and ventricular 
myocytes and purkinjie fibers. These cells depolarize rapidly, conduct stimulation rapidly 
to the adjacent cell, and have a sustained plateau phase.77-80 Slow response action 
potential occur in pacemaker cells, the SA and AV nodes of the heart. These cells 
depolarize spontaneously, slowly and have a shorter plateau phase. 77, 79, 80 
Fast- response action potentials.  
The working myocardial cells of the atria and ventricles and Purkinje fibers are 
examples of fast response action potentials. 77-80 Fast-response cells have a resting 
membrane potential of approximately -90mv. Excitation of these cells by an action 
potential from an adjacent cell causes a rapid depolarization to a threshold voltage of 
about -60 to -65 mV.  Once this threshold voltage is reached, the Na+ channels open and 
a large  inward directed, depolarizing Na+ currents (INa) enter the cell and the initial 
overshoot upstroke (Phase 0) occurs with a peak voltage of +20 to +30 mV.  The 
overshoot is brief because the Na+ channels automatically inactivate after a few 
milliseconds.  
At early repolarization (phase 1), the Na+ channels are spontaneously and rapidly 
inactivated, but a special type of transient outward K+ channel (ito) opens, causing a 
small, early, rapid but incomplete repolarization of the cell to approximately +10 mV. At 
Phase 2 (plateau), the increase in inward Ca+2 current (iCa) down the electrochemical 
gradient through L-type calcium channels is nearly counterbalanced by the repolarizing 
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effect of the outward K+ current (IK1), resulting in a plateau period in the region of 0mV, 
which lasts 200-400 msec. During this phase, the increase in Ca+2 entry has a positive 
inotropic effect on the myocardial cells during contraction. The increase in cytosolic Ca+2 
concentration that occurs during plateau activates the Na+-Ca+2exchanger. The Na+-Ca+2 
exchanger allows three extracellular Na+ to enter the cell in exchange for one Ca+2 
expelled outside the cell.  The plateau inward Na+ current created by the Na+-Ca+2 
exchanger maintains the late plateau. Eventually, at phase 3, the delayed rectifier K+ 
currents dominate  and Ca+2 channels becomes inactive, causing rapid repolarization of 
the cell back to the -90 mV resting membrane potential.  
Physiological and pathological changes in action potential plateau.  
Duration of the action potential plateau is determined mainly by the size of K+ 
currents.77-80 In circumstances of tachycardia induced by sympathetic nerve stimulation, 
action potential shortens due to the increased size of repolarizing K+ currents.  
During hypoxia, ATP concentration falls while ADP and H+ concentrations rise, 
which in turn increases the opening of KATP channels. The resulting increase in K+ 
currents not only induces early repolarization and shortens the action potential but also 
decreases Ca+2 entry during action potential. Decreased Ca+2 entry has negative inotropic 
effect. High sympathetic nerve activity in ischemic hearts triggers cardiac dysrhythmias. 
In chronic heart disease and heart failure, the action potential lengthens. The 
genetic abnormality of the delayed rectifier K+ channels (long Q-T syndrome) that occur 
in chronic heart disease prolongs the action potential plateau and leads to Ca+2 overload 
and afterdepolarization, which may in turn triggers arrhythmia.77-80  
Antiarrhythmic drugs can alter the action potential of fast-response cells. β- 
adrenergic agonists increase the duration and amplitude of the plateau by increasing Ca+2 
currents. Sodium-channel blockers inactivate fast Na+ channels and decrease the slope of 
phase 0. Potassium-channel blockers delay repolarization (phase 3) by blocking the K+ 
channels.77-80  
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Slow response action potential.  
The slow response action potential is most often found in the SA and AV nodes. 
These cells have the ability to depolarize spontaneously, a property called 
automaticity.Unlike non-pacemaker action potentials, the action potential in nodal tissue 
has only 3 phases. Phase 0 is determined primarily by the currents through T- and L-type 
slow inward calcium channels.  
The SA node does not involve fast Na+ currents. The SA and AV nodal tissues 
depolarize spontaneously during phase 4 via the funny channels (If).  During phase 4 and 
when membrane potential is about -60 mV, the funny channels (If) open and conduct 
slow, inward Na+ currents causing the membrane potential to depolarize spontaneously. 
When the membrane potential reaches about -50 mV, the T- and L-type calcium channels 
open, consequently causing Ca+2 influx and the membrane continues to depolarize until 
an action potential threshold is reached (usually between -40 and -30 mV). 
Repolarization (Phase 3) occurs as K+ channels (Ik) open and the L-type calcium channels 
become inactivated and close.77-80  
Although nodal tissue depolarizes spontaneously, its rate of firing is altered by 
many factors such as the ANS.  The SA node is highly innervated by sympathetic and 
parasympathetic fibers. Parasympathetic (vagal) activation dominates over sympathetic 
influences at rest, while sympathetic activation dominates during stress and exercise. 
Acetylcholine released by vagal nerve decreases the SA activation rate by increasing K+ 
and decreasing slow inward calcium and Na+ currents. Norepinephrine released by 
sympathetic fibers increases pacemaker rate by decreasing K+ and increasing slow 
inward calcium and Na+ currents.77-80 
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Absolute and relative refractory periods. 
Refractoriness refers to the inability of cardiac tissue to be re-excited. During 
depolarization, the cell goes through a period in which it becomes refractory to 
subsequent depolarizing events. This period is generally divided into 2 phases: the 
absolute refractory period and the relative refractory period. The absolute refractory 
period involves phases 0, 1, 2, and part of phase 3. During absolute refractory period, no 
new action potential can be initiated, regardless of the magnitude of the stimulus. The 
absolute refractory period serves as a protective mechanism against reentry 
dysrhythmias.77, 79 
During the relative refractory period, the Na+ and Ca+2 channels are closed but are 
capable of activation. Thus, only a stimulus that exceeds the normal threshold can initiate 
a subsequent depolarization. 77, 79  
Overall, action potential initiates organized sequence of contractions in the heart. 
The phases of action potential vary from region to region in the heart. The longest 
duration of these action potentials is found in the cells of Purkinjie fibers, which works as 
a safeguard against re-entrant dysrhythmias.  
Cardiac dysrhythmias  
Cardiac dysrhythmias,  any abnormality in normal cardiac rhythmic pattern, are 
common and important clinical problems in patients receiving MV or undergoing the 
process of weaning from MV.17 Cardiac dysrhythmias result primarily from either 
abnormalities of impulse formation, impulse conduction, or both.77, 79 Abnormal 
automaticity, triggered activity and reentry mechanisms are responsible for the most 
clinically important and potentially malignant dysrhythmias such as ventricular ectopic 
beats, ventricular tachycardia/fibrillation, atrial fibrillation/flutter, and supraventricular 
tachycardia. 82, 83 In addition, abnormalities of mechanical loading (i.e., increased 
intrathoracic vascular volume) can induce dysrhythmias through a mechano-electrical 
feedback mechanism.46, 65, 67, 68, 70, 72, 73, 84 
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Abnormal automaticity. 
Automaticity refers to the ability of cardiac cells to depolarize spontaneously and 
initiate an electrical impulse without the effect of external stimuli. 77-79, 81 Abnormal 
automaticity is an abnormal condition generated by sustained ventricular excitability and 
repetitive afterdepolarization.77-79, 81 Conditions such as ischemia, hypoxia, acidosis, and 
hyperkalemia can induce abnormal automaticity.77-79, 81  
Ischemia and hypoxia mainly interfere with the function of the Na+-K+ pump. 
Reduction in the amount of oxygen necessary for the pump operation, results in reduction 
of the resting membrane.  When the resting membrane potential is reduced, the cell reach 
threshold more rapidly and  becomes abnormally permeable to Na+ during action 
potential phase 4, producing spontaneous depolarization.77-79, 81 Dysrhythmia that may 
result from abnormal automaticity include premature atrial and ventricular extrasystoles 
(PACs, PVCs, respectively), and idioventricular rhythms.77-79, 81  
Triggered activity. 
Triggered activity is an abnormal condition of pacemaker and myocardial non-
pacemaker cells in which the myocyte depolarizes during action potential phase 2, phase 
3, or phase 4 after repolarization is complete.77-79, 81 Resulting beats are called triggered 
beats as they are triggered by prior beats. Triggered activity is characterized by the 
occurrence of afterdepolarization.  Afterdepolarizations that develop during phase 2 or 3 
are called early afterdepolarization (EAD) and those that develop in phase 4 after 
repolarization is complete are called delayed afterdepolarization (DAD).77-79, 81 
Early afterdepolarization that occurs during phase 2 or early in phase 3 results 
from activation of slow calcium channels. While EAD that occur late during phase 3 
results from large inward Na+ currents generated by calcium overload. 82, 83 Once an EAD 
reaches threshold, a second early beat “i.e., triggered beat” arises as result of preceding 
action potential. Each triggered beat may precede another abnormal impulse resulting in 
several abnormal beats. 
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Early afterdepolarization can develop under conditions of hypoxia, acidosis, 
hypokalemia, hypomagnesemia, hypothermia, high PCO2, and high concentrations of 
catecholamines, and develops in areas of stretch or mechanical injury.  Early 
afterdepolarizations are more likely to give rise to serious dysrhythmias such as long QT 
syndrome, torsades de pointes, and polymorphic ventricular tachycardia.77-79, 81   
High concentrations of catecholamines, digitalis, and hypokalemia trigger 
development of DAD and cause serious arrhythmias such as accelerated junctional 
rhythm and ventricular tachycardia in singles, pairs or paroxysms.77-79, 81  
Reentry. 
Reentry, a type of conduction abnormality, occurs when an impulse enters and 
reenters a previously depolarized area and depolarizes it again. 82, 83  The path over which 
the impulse travels to excite and re-excite a portion of cardiac tissue is called re-entrant 
circuit.  Reentry is the mechanism of the vast majority of clinically relevant 
tachyarrhythmias.77-79, 81 Reentry occurs in areas of unidirectional block, in which 
impulses conduct in one direction and reenter it again with low velocity to continue 
propagation in a circular manner, resulting in a run of premature beats or sustained 
tachycardia. 
Conditions that induce reentry can be grouped under: 1) shortening of cell 
refractoriness caused by sympathetic stimulation, 2) lengthening of the conduction 
pathway such as in hypertrophy, and 3) slowing of impulse conduction as manifested 
during ischemia.77-79, 81  Clinical arrhythmias that are caused by reentry mechanism 
include ventricular tachycardia, atrial fibrillation, atrial flutter, and Wolff- Parkinson- 
White syndrome. 
Stretch and mechano-electrical feedback mechanism. 
Mechano-electrical feedback is a term that describes electrophysiological changes 
caused by regional mechanical stretch or global hemodynamic over-load mediated by 
stretch- activated ion channels.  The mechano-electrical feedback mechanism is 
characterized by shortening of action potential duration, a decrease in the resting diastolic 
potential, and development of EAD and ectopic beats.  
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The mechano-electrical feedback mechanism may play a role in arrhythmogenesis 
in patients with impaired ventricular function or in regionally or globally impaired dilated 
hearts or in hearts subject to pressure /volume overload or failure.85-89 
In general, arrhythmogenic conditions, such as hypoxemia, hypercarbia, acidosis, 
hypokalemia, hypomagnesemia, high concentrations of catecholamines and digitalis, 
myocardial stretch or mechanical injury trigger the mechanisms of abnormal automaticity, 
triggered activity and reentry.82, 83, 90, 91  
Heart rate variability 
The autonomic nervous system (ANS) is an important component of the 
physiology of heart rhythm. A link between ANS alteration, specifically increased 
sympathetic activity and decreased parasympathetic activity (as reflected by decreased 
HRV), and the occurrence of dysrhythmias was demonstrated in numerous experimental 
and clinical studies.35-42, 44, 92  
Heart rate variability is the analysis of beat-to-beat variation in heart rate. 
Variability of heart rate results, in large part, from ongoing changes in sympathetic and 
parasympathetic inputs to the SA node.  
Heart rate variability is a noninvasive indicator of autonomic neural regulation of 
the heart,93 and is used as a valuable diagnostic and risk stratifying strategy in patients 
with cardiac diseases as well in normal populations. Decreased HRV has been associated 
with increased mortality in patients with heart failure,94 and acute myocardial 
infarction.95, 96 In addition, HRV is considered a powerful predictor of sudden cardiac 
death and dysrhythmic events in patients with underlying cardiac dysfunction.37, 42, 43, 97, 98  
Heart rate variability and weaning from mechanical ventilation. 
Respiratory sinus arrhythmia (RSA) is a normal phenomenon that refers to the 
cyclical variation in heart rate during the respiratory cycle, such that the heart rate 
accelerates during inspiration and slows during expiration. Sinus arrhythmia is mainly 
mediated through changes in efferent vagal activity. Vagal activity is influenced by 
stretch receptors in the lung and by baroreceptors located in the carotid sinuses and aortic 
arch. Lung inflation that occurs during inspiration stimulates the vagal nerves in the lung 
and induces a reflex tachycardia. During expiration, increases in blood pressure stimulate 
baroreceptors and hence reflex bradycardia is seen.99  
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Weaning, the process of transition from MV to spontaneous ventilation, is 
associated with alterations in ANS tone, reflected by decreased HRV especially in 
patients with underlying cardiovascular dysfunction and impaired compensatory 
mechanisms. Alteration in HRV during weaning and its relation to weaning outcome was 
investigated in both animals and human subjects.  Shen et al.34 analyzed HRV in 24 
patients during transition from pressure support ventilation (PSV) to spontaneous 
breathing trial (SBT). The investigators found a significant decrease in LF and HF HRV 
in the group of patients who failed the weaning process, but not in the success group.  In 
animal study, Frazier et al.33 found a significant increase in VLF power and a significant 
decrease in HF power with exposure to a combination of pressure support and continuous 
positive airway pressure (PS+CPAP) in a group of six canines. The reduction in HF 
power could be explained as a result of the withdrawal of parasympathetic nervous 
system activity, increased respiratory rate and decreased tidal volume that occur during 
weaning. Frazier et al.100 demonstrated that patients who failed their initial weaning trial 
had reduced HRV during ventilation and further decreased HRV during the weaning trial. 
Heart rate variability and dysrhythmias. 
Numerous investigators have demonstrated a significant relationship between 
reduced HRV, genesis of malignant ventricular dysrhythmias (Primarily ventricular 
fibrillation and ventricular tachyarrhythmias), and mortality. 35, 41-43, 45, 101 Clinical 
researchers have shown reduced HRV with a shift toward sympatho-vagal imbalance 
(i.e., increased sympathetic and/or reduced vagal tone) to occur before the expression of 
dysrhythmias.39, 40  
An increase in parasympathetic tone is considered a protective mechanism for the 
heart. Increases in sympathetic tone are strongly associated with the genesis of 
ventricular dysrhythmias caused by the three electrophysiologic mechanisms: reentry, 
triggered activity, and automaticity.  
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Most studies that describe a relationship between reduced HRV and occurrence of 
cardiac dysrhythmias were limited to patients with cardiovascular diseases especially 
heart failure, acute myocardial ischemia and myocardial infarction. 35, 36, 102 Studies have 
shown that imbalances toward adrenergic predominance are associated with susceptibility 
to dysrhythmia.35, 36, 102 That is because sympathetic stimulation decreases ventricular 
refractoriness and increases myocardial excitability. 
Numerous investigators reported significant alterations in ANS balance, with a 
shift toward increased sympathetic activity or decreased parasympathetic activity or both, 
and initiation of ventricular arrhythmias. Huikuri et al.103 reported a significant decrease 
in HF power one hour preceding the onset of the ventricular tachycardia in patients with 
ischemic heart disease. Fei et al.39 reported a significant increase in the LF/HF ratio 
immediately before the onset of ventricular tachycardia episodes. The investigators 
attributed the increase in the LF/HF to the decrease in parasympathetic activity rather 
than enhanced sympathetic activity in patients with heart diseases. In contrast, Hayashi et 
al.40 reported that the increase in the LF/HF before the onset of ventricular tachycardia 
was attributed to the sympathetic dominance in patients without structural heart diseases. 
Several studies have shown a shift toward an increase in sympathetic tone or a loss of 
vagal tone before occurrence of paroxysmal atrial fibrillation36, 102 and atrial flutter 104 in 
patients with underlying heart diseases. 
Heart rate variability measurement.  
The analysis of HRV is usually performed using commercial software. After 
appropriate confirmation of heart beats obtained with Holter recordings and filtering 
artifacts, a series of RR intervals (RR tachogram) is used to quantify HRV.105 The RR 
interval (sometimes called normal-to-normal [NN] interval) is the time interval between 
the R waves of two consecutive normal beats.  Traditionally, two major approaches are 
often used to measure HRV, time domain and frequency domain analyses.  Several 
investigators used these two methods as complementary to each other. 
Time domain analysis.  
Time domain analysis is the simplest to perform. It is based on the statistical 
calculations of standard deviation of NN intervals, coefficient of variance, short-and 
long-term components of HRV. Time domain measures of HRV are defined in Table 2.1 
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according to the recommendations of a Task Force Committee.106 Commonly used time 
domain measures include standard deviation of normal RR interval (SDNN), the standard 
deviation of the average of NN intervals in all 5 min segments of the entire recording 
(SDANN), the square root of the mean of the sum of the squares of differences between 
adjacent NN intervals (MSSD), and the percentage of successive normal RR intervals 
that change by more than 50 ms compared to the total number of RR intervals (pNN50). 
 
Table 2.1: Time domain measures of heart rate variability 
Variable Statistical measures  
SDNN [ms] Standard deviation of all NN intervals 
SDANN [ms] Standard deviation of the average of NN intervals in all 5 min 
segments of the entire recording 
RMSSD [ms] Square root of the mean of the sum of the squares of 
differences between adjacent NN intervals 
SDNN index [ms] Mean of the standard deviations of all NN intervals for all 5 
min segments of the entire recording 
NN50 count Number of pairs of adjacent NN intervals differing by > 50 
ms in the entire recording 
pNN50 [%] NN50 count divided by the total number of all NN intervals 
Triangular index Total number of all NN intervals divided by the height of the 
histogram of all NN intervals measured on 
discrete scale with bins of 1/128 s 
 
Frequency domain analysis. Frequency domain analysis, or spectral analysis of 
HRV, is a technique that provides distinct measures of the vagal as well as the 
sympathetic modulation of the heart. Frequency domain measures of HRV are defined in 
Table 2.2 according to the recommendations of a Task Force Committee.106 
 
Table 2.2: Frequency domain measures of heart rate variability  
Variable Statistical measures  
Total power [ms2] Variance of all NN intervals 
ULF [ms2] Power in the ultra low frequency range (≤0.003 Hz) 
VLF [ms2] Power in the very low frequency range (0.003–0.04 
Hz) 
LF [ms2] Power in the low frequency range (0.04–0.15 Hz) 
HF [ms2] Power in the high frequency range (0.15–0.4 Hz) 
ULF= Ultra low frequency; VLF= Very low frequency; LF= Low frequency; HF= High 
frequency 
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 The technique of power spectral analysis involves decomposing the heart rate 
signal into a sum of sine waves as a function of frequency.  The squared amplitude (i.e., 
power) of spectral components are displayed on a plot in which the power spectral 
density (PSD) of HRV versus frequency are poltted.106 The total area under the curve of 
the PSD versus frequency plot is equal to the total statistical variance, or the power of the 
signal. These power distributions are calculated for defined frequency bands (Figure 2.1) 
and are interpreted as an estimate of the variance of the HRV signal within the bands of 
HF, LF, VLF, and ULF.44, 106 The HF component (0.15-0.40 Hz) represents the vagal 
control to the heart,93 modulated by respiration.107-109 The LF (0.04-0.15Hz) component is 
more controversial and has contribution from both, vagal and sympathetic modulation of 
the heart.94, 108, 110 But, many investigators proposed the LF as an index of sympathetic 
modulation.93 Very low frequency power (0.003–0.04 Hz) represents the sympathetic 
activity.  The ratio of LF to HF (LF: HF) is used as an index of sympatho-vagal balance 
of the ANS.93, 106, 111 Short term recordings (up to 5 minutes) yield 3 peaks which are high 
frequency (HF), low frequency (LF), and very low frequency (VLF). While long term 
measurement (24 hrs) allows the measurement of ultralow frequency (VLF).  
 
Figure 2.1: Power spectral analysis of heart rate variability at baseline for one 
subject enrolled in the study 
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The PSD can be estimated using a parametric (autoregressive [AR]) or a 
nonparametric (Fast Fourier transform algorithm [FFT]) method.106 The FFT is easier to 
use and it requires a priori selection of the  frequency range of bands of interest.112  
In summary, findings from clinical studies suggested that the ANS status is a 
major determinant and a contributing mechanism in the generation of cardiac 
dysrhythmias. Sympathetic activation and/or vagal withdrawal reflected as reduced HRV 
increased the risk of developing lethal dysrhythmias. Measurement of HRV provides 
significant information concerning the sympatho-vagal balance in the control of 
cardiovascular function. 
Weaning from Mechanical Ventilation 
Mechanical ventilation is widely used to support ventilatory function in critically 
ill patients. However, prolonged MV is associated with a variety of risks and 
complications, which are associated with high morbidity and mortality rates, increased 
hospital and ICU length of stay, and costs.1, 113 Therefore, weaning from MV as early as 
possible is an important goal for mechanically ventilated patients. 
The appropriate time of weaning should be selected carefully. Needless and long 
MV increases the risk of ventilator-associated pneumonia, increased ICU length of stay, 
and mortality. Alternatively, premature weaning imposes severe stress on the respiratory 
and cardiovascular systems, which is associated with high complication rate, morbidity, 
and mortality.8, 114 
Weaning is the process during which MV is gradually withdrawn and 
spontaneous breathing is resumed. This process represents approximately 41% of the 
total time spent on MV.1, 115 At the 5th International Consensus Conference in Intensive 
Care Medicine, Tobin116 described the weaning process as a continuum consisting of a 
series of six stages lasting from intubation until hospital discharge. 
As a brief description of this process, weaning from MV begins with treatment of 
acute respiratory failure (stage 1). When the underlying cause of acute respiratory failure 
stabilizes or significantly improves, the potential for weaning is considered (stage 2) and 
daily assessment of the patient’s readiness for ventilator discontinuation is considered 
(stage 3). Patients who meet the criteria for readiness to wean go through a spontaneous 
breathing trial (SBT) (stage 4). Those who can tolerate the trial and are able to follow 
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commands are extubated (stage 5), while those who cannot are returned back to full 
ventilatory support for at least 24 h before performing a new trial.  Patients who are 
extubated and cannot maintain spontaneous breathing for 24 to 72 hours after extubation 
are reintubated (stage 6).  
Until recently, the decision to wean was based on physician’s judgment and 
clinical experience. In the last few years, numerous clinical trials were conducted to 
establish evidence-based protocols to standardize the process of weaning. In some ICUs, 
protocols driven by respiratory therapists or ICU nurses are used for daily assessment to 
determine when patients are ready to start the weaning process. Compared to traditional 
care, weaning protocols resulted in better outcomes in some studies, such as significant 
decreases in the duration of MV, ventilator-associated pneumonia, weaning time, 
complication rate, ICU length of stay, costs, reintubation rate, and use of sedative 
infusion.9, 117-120 
Spontaneous breathing trials. 
Implementing an evidence-based weaning protocol involves two major steps: 1) 
daily assessment of readiness to wean; and 2) performing a SBT (Figure 2.2). 
A SBT  is an assessment test to determine if a patient needs to be continued on 
MV or can be successfully extubated.18 A SBT should be considered as soon as the 
patient meets the criteria for readiness to wean. 
Clinical criteria to determined readiness for weaning were recommended by the 
multisociety-sponsored evidence- based task force 18 and include (1) evidence of lung 
injury resolving or stabilizing; (2) adequate oxygenation, (SpO2 ≥ 90%  with PEEP <5 to 
8 cmH2O, FiO2 <0.4 to 0.5); (3) stable hemodynamics with minimal or no pressor 
treatment; and (4) ability to  initiate spontaneous breathing effort. 
Patients who meet the criteria of readiness to wean, undergo a SBT. The SBT can 
be conducted using low levels of pressure support (5 to7 cmH2O), continuous positive 
airway pressure (CPAP), or a T-piece with supplemental oxygen 9, 10, 18, 121, 122 and lasts 
for at least 30 minutes, but no longer than 2 hours.18, 122   
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During the SBT, the patient’s respiratory pattern, hemodynamic status and 
comfort are monitored continuously. Although not all weaning protocols have the same 
guidelines,  Many protocols consider the SBT successful if the patient has a PaO2/FiO2 ≥ 
150 to 200, PEEP ≤ 6 cm H20, rapid shallow breathing index (RSBI) < 105,  and stable 
hemodynamics with no or minimal vasopressors.  Patients who successfully complete a 
SBT are considered for extubation if they are awake, able to protect their airway, 
demonstrate effective coughing strength and have minimal need for suctioning.122 
Weaning success is defined as extubation, and spontaneous breathing with no ventilatory 
support for 48 hours following extubation. 
Conversely, the SBT is defined as a failure if the patient experiences sustained 
tachypnea (RR > 35 breaths/min), respiratory distress, decreased oxygen saturation (SpO2 
< 90% with FiO2 > 50%), RSBI >105, increase of heart rate > 20 beats/minute above 
baseline or systolic BP > 20 mmHg above baseline, new dysrhythmias, respiratory 
acidosis, agitation, diaphoresis, and depressed mental status.122, 123 Those patients who 
fail a SBT are returned to full ventilatory support for at least 24 hours for respiratory 
muscle rest. Causes that contributed to weaning failure are identified and treated before 
performing another trial. Weaning failure is defined as a failed SBT and/or reintubation 
within 24-72 hours following planned extubation.122 
Reintubation is considered if patients experience a decline in mental status, 
respiratory failure, or significant hemodynamic instability.123, 124 Unfortunately, 
extubation failure and reintubation are  associated with high risk of nosocomial 
pneumonia,123 hospital mortality, prolonged ICU and hospital stays, increased need for 
tracheostomy and long term acute care.8, 114, 115 
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Modes of weaning from Mechanical Ventilation. 
Several modes and techniques are used to facilitate weaning including 
synchronized intermittent mandatory ventilation (SIMV), T-piece, CPAP and pressure 
support ventilation (PSV).115 Synchronized intermittent mandatory ventilation is a 
ventilatory and weaning mode in which a preset of volume or pressure mandatory breaths 
are delivered in coordination with patient’s spontaneous breaths effort (i.e., patient 
triggered). If the ventilator was not triggered by the patient, mandatory breaths are 
delivered according to the set rate. The goal of SIMV weaning is to gradually decrease 
the number of breaths delivered by the ventilator, allowing the patient to take more 
breaths of his or her own.7 
Pressure support ventilation is a form of assisted ventilation, often used to 
decrease work of breathing. With PSV, the patient triggers the ventilator and the 
ventilator delivers a preset pressure of gas. Weaning using PSV consists of setting the 
inspiratory pressure and PEEP to achieve a spontaneous tidal volume of 10-12 ml/Kg; 
and the patient regulates the respiratory rate and tidal volume. During weaning, the 
pressure support level is decreased gradually according to patient’s tidal volume and 
respiratory rate.7 Pressure support ventilation is used during the weaning process in 
around 26% of patients. 115 
T-piece trials consist of alternating intervals of time on the ventilator with 
intervals of spontaneous breathing. A T-piece circuit consists of a T-shaped tube that is 
attached to the endotracheal or tracheostomy tube. One end of the tube is attached to an 
oxygen flow meter and the other end is open. The goal of using a T-piece is to administer 
supplemental oxygen while gradually decreasing the amount of time spent off the 
ventilator.7  
Several investigators reported and compared the rate of weaning success, length 
of ventilation and duration of weaning attempts using different weaning modes. Brochard 
et al.125 randomly assigned 456 patients to be weaned with PSV or SIMV, or T-piece. 
They found that patients exposed to PSV had shorter duration of weaning compared to 
the patients in the other two groups. Matic et al.63 randomly assigned 260 patients to a 2-
hour weaning trial using T-tube (n=110) or PSV (n=150). The investigators reported that 
80 (73%) patients in the T-tube group and 120 (80%) patients in PSV group were 
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successfully weaned and extubated. In patients with weaning difficulties, length of 
ventilation, time of weaning, and length of stay was significantly shorter (p<0.001) in 
patients who underwent a PSV trial. Esteban et al.9 found that one daily trial or multiple 
daily trials of weaning using T-piece in 130 patients who failed the initial SBT 
considerably reduced the duration of weaning than either SIMV or PSV. Applying CPAP 
during spontaneous breathing improves right and left ventricular performance by 
decreasing its afterload, and improves oxygenation. Squadrone et al. 126 observed in a 
multicentre randomized controlled trial, that patients who developed severe hpoxemia 
after abdominal surgery and received CPAP plus oxygen therapy had lower rate of 
reintubation, occurrence of pneumonia, infection, and sepsis compared to oxygen 
supplementation alone. In conclusion, there is no better weaning mode. Weaning mode 
should be selected by physicians and respiratory therapists according to patient’s status 
and needs. 
Predictors of weaning outcome. 
A number of parameters have been found to be associated with success or failure 
of ventilator discontinuation.127 Some of these parameters were considered as predictors 
by several investigators. Predictors include age, medical diagnosis, hemodynamics, lung 
mechanics, gas exchange, severity of illness, duration of ventilation prior to weaning, and 
symptoms of diaphoresis and agitation. The relevance and significance of these predictors 
vary among different patient populations.  
Several investigators reported some measurable parameters as significant 
predictive indices of weaning outcome. Some of these indices include PaO2/FiO2, 
respiratory system static compliance, maximum inspiratory pressure (MIP), mixed venous 
oxygen saturation (SvO2),75 work of breathing (WOB), gastric mucosal pH,128 rapid 
shallow breathing index (RSBI),  acute physiology and chronic health evaluation  
(APACHE score), and arterial blood gases.122 For the purposes of this study, we focused 
on RSBI and severity of illness upon ICU admission as measured by APACHE score. 
That is because some investigators reported that RSBI >100 breaths/min/L 129, 130 and 
high APACHE score129, 131 are significant predictors of weaning failure. 
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The RSBI is the ratio of respiratory frequency to tidal volume (f/VT) calculated 
during spontaneous breathing. The RSBI is affected by patient’s underlying 
cardiovascular and respiratory status. Several investigators studied the significance of 
RSBI as a predictor of weaning outcome in different patient populations and 
controversial results were found. Some investigators reported that RSBI value <100–
105 breaths·min–1·L–1 predicts a successful SBT with a reported sensitivity of 0.97 and 
specificity of 0.64.132 while a value of >100 breaths/min/L129, 130 predicts failed weaning 
trials. Other investigators reported that RSBI was not a significant predictor of weaning 
failure.122, 133, 134  
The APACHE is a severity-adjusted methodology that predicts outcomes for 
critically ill adult patients. Twenty seven variables are collected for each patient. These 
variables include the diagnosis, age, vital signs (temperature, mean arterial pressure, heart 
rate, respiratory rate), and laboratory values (such as serum potassium, creatinine, 
albumin, bilirubin, white blood cell count, and hemtocrit). These data, in conjunction 
with comorbidities, are combined and used to formulate a predictive equation for each 
individual patient. These predictions are made for mortality (both ICU and hospital), 
length of stay (both ICU and hospital), ventilatory days, and the need for active 
treatment.135-138 
The APACHE IV score (range 0-299) is formed by the sum scores of the acute 
physiology score (range from 0-252), chronic health score (range from 0-23) and age 
score (range from 0-24). The acute physiology score is the total number of points that the 
patient earns from disturbed physiology alone. Chronic health includes more than thirty 
chronic health items that affect the immune system. Some of these chronic health items 
include AIDS, acute or chronic myelogenous or lymphocytic leukemia, multiple 
myeloma, non-Hodgkin’s lymphoma, solid tumor with metastasis, presence of an 
immunocompromised state (secondary to chemotherapy, radiation, or drug therapy), 
hepatic failure with cirrhosis and jaundice and ascites, UGI bleeding, encephalopathy, or 
coma, and diabetes mellitus. 
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Physiological determinants of weaning outcome. 
Weaning success is defined as extubation and spontaneous breathing with no 
ventilatory support for 48 hours following extubation.9 Conversely, weaning failure is 
defined as a failed SBT and/or reintubation within 24-72 hours following extubation.122, 
139  Weaning failure occurs as a result of respiratory drive failure, impaired lung 
mechanics, diaphragmatic dysfunction, hypoxemia,75 cardiovascular dysfunction, sepsis, 
and positive fluid balance in the 24 hours before weaning,130 in addition to airway 
obstruction or excessive secretions and pneumonia.123 Extubation failure may also be 
related to the same reasons. 
Unfortunately, failed weaning trials and failed extubation, ultimately prolong the 
duration of MV. Up to one-third of patients experience difficult and prolonged weaning. 
Prolonged MV is defined as patients’ need to ventilatory support for >72 hours or even 
more.139, 140 Patients with difficult and prolonged weaning have higher incidence of ICU 
mortality than those patients who wean easily. The high mortality rate results from the 
underlying disease and/or complications associated with MV, especially ventilator-
associated pneumonia. 
Summary 
Up to 90% of patients admitted to ICUs require MV. The use of MV is associated 
with increased morbidity, mortality and greater financial costs. Thus, it is important to 
discontinue MV as soon as feasible. However, weaning from MV can produce 
hemodynamic alteration (i.e., intrathoracic vascular volume and flow), and alterations in 
ANS (reflected by decreased HRV). Decreased HRV can cause dysrhythmias especially 
in patients with underlying cardiovascular disease. Cardiac dysrhythmias can decrease 
cardiac output, induce myocardial ischemia, worsen respiratory failure and thus 
negatively affect length of MV.   
There is paucity of research about cardiac dysrhythmias during weaning from MV 
and its impact on length of MV. Studying and identifying cardiac dysrhythmias that occur 
during MV and weaning, and determining the role that dysrhythmias might play in length 
of MV are vital in order to provide appropriate care and management for mechanically 
ventilated  patients. 
Copyright© Muna Hassan Hammash 2010 
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CHAPTER III: 
MATERIALS AND METHODS 
Design 
In this longitudinal, repeated measures design, we collected data to evaluate the 
impact of changes in HRV during weaning from MV on the development of cardiac 
dysrhythmias and the impact of cardiac dysrhythmias on length of ventilation. Data were 
collected on the following variables: 1) HRV (measured by examination of the beat-to-
beat variability of heart rate continuously collected using Holter recording techniques and 
evaluated in the frequency domain); 2) dysrhythmias (measured by continuously 
collected ECG data using Holter recording techniques); and 3) length of MV. Data were 
measured for each subject at baseline during MV and during the initial weaning trial from 
MV. Comparison of each subject’s baseline data with weaning data allowed each subject 
to serve as their own control.  
Sample and Setting 
A convenience sample of 35 adult patients was enrolled from the medical 
intensive care unit (MICU), surgical intensive care unit (SICU), cardiac care unit (CCU) 
and trauma intensive care unit (TICU) at the University of Kentucky Chandler Medical 
Center (UKMC), Lexington, Kentucky.  
The MICU is an 8-bed unit. It provides care for a mean monthly census of 40 
patients. About 67% of these patients required MV support during their ICU stay.  The 
CCU is an 8-bed unit. An average of 37 patients per month is admitted to the CCU. 
Approximately, 44% of admitted patients required MV for an average of 6.1 days. The 
SICU is a 6-bed unit. An average of 33 patients per month is admitted to the SICU. 
Around 67% of admitted patients required MV for an average of 11.7 days. The TICU is 
an 8-bed unit. An average of 35 patients per month received care in TICU. Around 64% 
of admitted patients require MV for an average of 6.5 days.  
Patients of both genders and all races/ethnicities who were 18 years of age or 
older and received MV for a minimum of 24 hours via endotracheal tube were eligible to 
be included. The exclusion criteria for this study were patients who:  1) had a myocardial 
infarction within the past 3 months or were admitted with a myocardial infarction; 2) 
were undergoing cardiac surgery or underwent cardiac surgery within the last 3 months; 
3) had neurological trauma or stroke within the last 3 months or were admitted with 
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neurological trauma or stroke; 4) were in atrial fibrillation or had bouts of atrial 
fibrillation; 5) had a pacemaker or implanted cardioverter defibrillator; or 6) had  a 
pulmonary artery catheter or central venous catheter that was not in proper position as 
confirmed by radiography. These exclusion criteria make patients more vulnerable to 
develop dysrhythmias and induce changes in HRV because of their underlying disease 
process, and not because of the effect of MV or weaning process.  
Ethical Review 
This study was approved by the Institutional Review Board (IRB) at the 
University of Kentucky (Appendix A). 
Measures 
Dysrhythmias 
The number of times the heart beats each minute and the rhythm of these beats, 
were evaluated by analysis of  cardiac electrical activity using a 3-lead, 24-hour ECG 
Holter recorder (459 Del Mar, Irvine, CA) with leads I, II, and V2. Holter recordings were 
scanned using a Del Mar Holter Analysis System (453A, Irvine, CA) in semiautomatic 
mode with operator confirmation of all beat types. The timing of QRS complex onset, as 
well as all beat types and artifact, were manually confirmed. Data about the number of 
ventricular, and supraventricular ectopic beats; and number of episodes of ventricular 
tachycardia/fibrillation, and atrial fibrillation/flutter were collected.  
These dysrhythmias were chosen because of their potential for serious impact 
upon hemodynamics and oxygen delivery and potential effect on weaning outcome and 
length of MV. Number of occurrences of each type of dysrhythmias, with the exception 
of atrial fibrillation/flutter and ventricular tachycardia, were referenced as beats per hour.  
Episodes of atrial fibrillation/flutter and ventricular tachycardia/fibrillation were 
referenced as present or not, and occurring after initiation of weaning or not.   
Heart rate variability (HRV)  
Heart rate variability refers to beat-to-beat fluctuations in heart rate and is a 
noninvasive indicator of autonomic tone. Heart rate variability is a predictor of risk of 
sudden cardiac death in patients with diabetes and myocardial infarction.141 For this study, 
frequency domain measures were used to reflect HRV. Frequency domain analysis or 
power spectral analysis decomposes a signal into a sum of sine waves of different 
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amplitudes and frequencies, and then presents the squared amplitudes of the sine waves 
as a function of frequency. The following spectral components were measured in this 
study: high frequency (0.15 to 0.40 Hz) which represents an index of parasympathetic 
activity; low frequency (0.04 to 0.15 Hz) which represents parasympathetic and 
sympathetic inputs, and very low frequency component (< 0.04 Hz), which represents 
sympathetic activity. 
Using the Del Mar HRV analysis software, the recording periods were divided 
into consecutive, non-overlapping 5-min epochs. Artifacts, atrial fibrillation/flutter and 
abnormal complexes along with the preceding and succeeding R-R intervals were 
excluded from the analysis and linear interpolation was used to estimate the instantaneous 
heart function. Segments in which more than 80% of its R-R intervals were not normal 
were excluded and a Hanning window applied.  A fast Fourier transformation was then 
done. Heart rate variability changes during weaning were assessed by averaging and 
comparing power spectra from the 5-min epochs during 24 hour baseline period of MV, 
and during the first two hours of the weaning process. 
Length of ventilation 
Length of MV was measured as the number of days the patient required MV. It 
started upon intubation and ended with MV discontinuation either by extubation or by 
receiving oxygen supplementation through tracheostomy. Data about length of ventilation 
were abstracted from patient medical record and respiratory therapy records. 
Socio-demographic characteristics and clinical data  
Demographic data including age, gender, marital status, type of insurance, 
ethnicity, height and weight were abstracted from the patient medical record .  
Clinical data including the past and current history of MV, history of cardiac 
diseases and dysrhythmias, reason of hospitalization, hospital and ICU length of stay 
before intubation were collected at baseline upon enrolling the patient into the study. 
Data about APACHE IV score, physiological status, pulmonary status, cardiovascular 
status, and intake and output status were collected from the medical record twice, for 
baseline during MV and for the weaning day (Appendix B).   
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The institutional review board approval was obtained from the University of 
Kentucky Medical Institutional Review Board for the conduct of this study. Each 
morning, the PI evaluated all patients receiving MV for inclusion criteria. Candidate 
patients who met the inclusion criteria were approached and recruited. The study purpose, 
data collection protocol, risks and benefits were explained and discussed with a patient 
surrogate. In this study, the patient surrogate provided the informed consent. The patient 
was assessed daily for competence to provide informed consent during the study period. 
Once the patient became competent, the study purpose, data collection protocol, risks and 
benefits were explained for the patient in the presence of his/her surrogate, and oral 
consent was obtained. 
The data collection timeline is described in Figure 3.1. At baseline, upon 
enrollment in the study, demographic and baseline clinical data were abstracted from the 
medical record. Skin on the chest was prepared to attach the electrodes for Holter 
monitoring. Preparation included carefully clipping of hair in areas where electrodes were 
to be placed if needed and/or cleaning the skin with alcohol to remove skin oils.142 Holter 
monitor electrodes for 3-leads were placed in the appropriate configuration as follows:  
(1) left anterior axillary line, 6th rib; (2) two centimeters right of the xiphoid process on 
the rib; and (3) left mid- clavicular line, 6th rib). Following visual confirmation of an 
adequate signal, a 24-hour continuous ECG recording was started.   
All patients enrolled in the study were evaluated every morning for readiness to 
wean by respiratory therapists and an attending physician. Readiness to wean was 
determined based on the following criteria: (1) resolution of the reason  for which the 
patient was intubated; (2) adequate oxygenation, (SpO2 ≥ 90% with PEEP <5 to 8 
cmH2O); (3) stable hemodynamics with minimal or no pressor treatment; (4) pH > 7.35; 
(5) patient temperature < 102 F; and (6) minimal to no sedation. Once the first weaning 
trial was prescribed by the attending physician, the PI attached a Holter monitor device as 
described earlier. ECG was continuously recorded during the weaning trial.  Clinical data 
collected at baseline were collected again during weaning from the medical record.  All 
data collection records and ECG records were coded by a subject number and stored in a 
locked file cabinet at the College of Nursing research area. 
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The PI reviewed all data forms for completeness and legibility to decrease 
missing data and possible erroneous entries and other problems. All data were collected 
on data forms developed by a team of researchers studying MV and weaning. All data 
collected were kept in password-protected files, entered and organized in dated folders 
stored on the College of Nursing secure server. 
Figure 3.1: Data Collection Timeline  
 
Baseline Data                                           Initial weaning trial 
             (Enrollment baseline)                                                                                                     
                                                                                                                                             
                                                                                         
 
 
Demographic data     
Clinical data      Clinical data   
Holter monitor (for 24 hours)   Holter monitor (for 2hours)   
Heart rhythm     Heart rhythm  
                         HRV                                                                HRV 
HRV = Heart rate variability 
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Data Analysis 
Before conducting analyses to test specific aims, data were cleaned. Frequency 
distributions were developed for all variables to detect and correct erroneous codes. 
Extreme, but possible codes were verified. Skewness and kurtosis were computed to 
identify those variables that might benefit from transformation to reduce any marked 
deviations from the normality assumptions of linear model analyses. Data analyses were 
performed using SPSS for Windows, version 16.0 (Chicago, IL). Descriptive statistics 
were used to characterize the sample. To further characterize the sample, repeated-
measures analysis of variance was used to determine differences across time in the 
variables of interest measured at baseline and during weaning. Differences were 
considered significant at an a priori α level of .05 or less. 
Specific Aim 1: To determine the relationship of ANS tone (reflected by HRV) 
during weaning to the development of cardiac dysrhythmias after controlling for baseline 
HRV measured during MV.  
Multiple linear regression was used to determine the relationship of HRV during 
weaning to the development of cardiac dysrhythmias. In order not to violate the 
assumptions of multiple regression analysis, ratio scores of independent variables were 
used to narrow the number of variables forced in each model. The ratio scores (i.e., 
average score at weaning divided by average score at baseline) of high frequency (HF), 
low frequency (LF), and very low frequency (VLF) were regressed separately on the 
mean score of occurrence of ventricular and supraventricular ectopic beats during 
weaning after controlling for APACHE IV score during weaning. In previous published 
studies, investigators used the value of APACHE score upon admission. In this study, the 
value of APACHE IV score during weaning was used to evaluate its impact on data 
collected during weaning. However, it is worthy to mention that there were no 
differences in results obtained using either the value of APACHE score on admission or 
during weaning. Separate models were developed to test the relationship of HRV during 
weaning in the frequency domain (HF, LF, and VLF frequencies) with each of the 
following outcomes: 1) number of ventricular ectopic beats per hour; and 2) number of 
supraventricular ectopic beats per hour.  No stepping procedure was used to test these 
models. 
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Specific Aim 2:   To determine the relationship between the occurrence of 
dysrhythmias during weaning and length of MV. Pearson correlation coefficients were 
computed length of MV, APACHE score at weaning, rapid shallow breathing index 
(RSBI), cumulative fluid balance based on 24 hour intake and output, and PaO2/FiO2.   
The length of MV was only correlated with APACHE score during weaning. Therefore, 
the value of APACHE score during weaning was controlled for in multiple regression 
models as described below. 
Multiple linear regression was used to evaluate the predictive power of cardiac 
dysrhythmias for length of MV, controlling for APACHE IV score during weaning. 
Variables were entered in two blocks: 1) the first block contained the variable to be 
controlled (APACHE IV score during weaning); and 2) the second block contained the 
number of ventricular ectopic beats per hour, and the number of supraventricular ectopic 
beats per hour separately.  No stepping procedure was used to test these models. 
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CHAPTER IV: RESULTS 
Sample Characteristics 
A total of 35 patients with a mean age of 53.3 years were enrolled in the study. Of 
the sample, 23 (66.7%) were men, 34 (97%) were Caucasian, 17 (49%) were married, 23 
(65%) were supported with government insurance, 11(31%) had a history of chronic 
pulmonary disease, 12 (38%) had received MV during a previous hospital admission and 
17 (49%) had a history of cardiovascular disease. Of those patients who reported the 
presence of underlying cardiovascular disease, 16% had a history of cardiac dysrhythmias. 
Patients enrolled in the study had different medical diagnoses upon admission such as 
neoplasms, pulmonary diseases, gastrointestinal conditions, liver and kidney diseases. 
Characteristics of the sample are summarized in Table 4.1. 
The majority of patients (72%) were mechanically ventilated for pulmonary 
conditions (e.g., acute respiratory distress syndrome, acute respiratory failure, pneumonia, 
and aspiration). Of the 35 patients enrolled in this study, 3 patients (8.6%) died, and 2 
patients (5.7%) required tracheostomy without a weaning trial. Two-thirds of the 30 
patients 23 (77%) failed the initial weaning trial and underwent an average of 2.8 
weaning attempts (range 0-11 trials) before successful weaning.  Patients were 
mechanically ventilated an average of 11.6 ± 8.4 days and stayed in ICU an average of 
15.6 ± 9.2 days. 
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Table 4.1: Characteristics of the sample (n=35) 
 Characteristic Frequency 
(%) 
Mean± SD OR 
Median (25th, 
75th percentile) 
Age, yr   53.3 ±14.6  
(Range 22-84) 
Sex 
 Male 
 Female 
 
23 (66.7) 
12 (34.3) 
 
Ethnicity 
Caucasian 
African- American 
 
34 (97.1) 
1 (2.9) 
 
Marital status 
Married 
Single/divorced/widowed 
 
17 (48.6) 
18 (51.4) 
 
Type of insurance 
Government 
Commercial and HMO 
Self 
 
23 (65.7) 
10 (28.6) 
2 (5.7) 
 
History of  pulmonary diseases 
Yes 
    No 
 
11 (31) 
24 (69) 
 
History of  mechanical ventilation 
Yes 
No 
 
12 (37.5) 
20 (62.5) 
 
History of  cardiovascular disease 
Yes 
    No 
 
17 (49) 
18 (51) 
 
History of  cardiac rhythm disturbances 
Yes 
    No 
 
5 (16) 
26 (84) 
 
Admission Diagnosis   
Pulmonary diseases 6 (17.4)  
Cardiac diseases 1 (2.9)  
Liver and kidney conditions 5 (14.5)  
Gastrointestinal conditions 9 (26.1)  
Nervous system conditions 4 (11.6)  
Trauma 4 (11.6)  
Other 6 (17.4)  
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Table 4.1 (Continued): Characteristics of the sample (n=35) 
Characteristic Frequency 
(%) 
Mean± SD OR 
Median (25th, 
75th percentile) 
Hospital length of stay prior to ICU admission, days  1 (0, 2)  
(Range 0-52) 
Hospital length of stay prior to intubation, days  0 (0, 1)  
(Range 0-52) 
Reason for current ventilation   
Pulmonary 25 (72.5)  
Neurologic 4 (11.6)  
      Surgical 6 (17.4)  
Results of initial weaning trials (n=30) 
Success 
Failure 
 
7 (23) 
23 (77) 
 
Number of weaning trials (n=30)  2.8 ± 2.6  
(Range 0-11) 
Length of mechanical ventilation, days  11.6 ± 8.4  
(Range 2-33) 
Length of hospital stay, days  28.9 ± 21.9  
(Range 9-101) 
Length of ICU stay, days  15.6 ± 9.2  
(Range 3-46) 
Length of ICU stay prior to tracheostomy (n=7), 
days 
 13.3 ± 6.9  
(Range 5-23) 
 
Changes in Clinical Characteristics 
Clinical characteristics at baseline during MV and at the initial weaning trial were 
compared using repeated measured ANOVA and are summarized in Table 4.2. Of the 35 
patients enrolled in this study, 5 patients (3 died, and 2 required tracheostomy before 
receiving any weaning trial) were excluded from further data analysis.  In addition, 
because some laboratory data were not ordered similarly, numbers of patients available 
for baseline and weaning data points were different across the variables. 
Of those clinical variables compared (Table 4.2), the Glasgow coma score (GCS), 
arterial oxygen saturation (SaO2), levels of calcium and magnesium, RBC count, 
hemoglobin and hematocrit, and cumulative fluid balance on weaning day differed 
significantly from those measured at baseline. The mean GCS increased significantly 
from 8.7 at baseline to 10.3 at the time of weaning (p = 0.001), indicating an 
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improvement in level of consciousness. The mean APACHE IV score at baseline was 
69.8, demonstrating a high severity of illness in this sample. The mean APACHE IV 
score on the weaning day (60.97) was not different of the value measured at baseline 
(p= .07). The mean SaO2 increased significantly from 95.93% at baseline to 97.67% at 
the time of weaning (p = 0.02). The baseline mean level of calcium (7.56 mg/dl) and 
magnesium (1.83mg/dl) increased significantly to 7.89 mg/dl and 2.02 mg/dl, 
respectively, at weaning time (p < 0.05). Also, RBC count, hemoglobin, and hematocrit 
decreased significantly by the time of weaning trial (p = 0.05).  On weaning day, mean 
positive fluid balance was significantly higher than at baseline (15340 ± 13765 mL 
versus 12364 ± 10559 mL, p < 0.05).  
 
Table 4.2: Comparison of patient clinical data at baseline during MV and on the day 
of initial weaning trial  
Variable  n Baseline MV Weaning day p  
Mean ± SD Range Mean  ± SD Range 
Patient’s 
temperature, 
F 
30 98.99 ± 1.41 96.2-
101.8 
98.96± 1.72 95.9-103.4 0.94 
Glasgow 
Coma Score 
30 8.7 ± 2.28 3-11 10.3 ± 1.26 6-14 0.00
1 
APACHE IV 
score 
30 69.8 ± 25.7 26-125 60.97 ± 20.36 16-111 0.07 
ABGs       
pH 28 7.4 ± 0.08 
 
7.21-7.55 
 
7.41 ± 0.07 
 
7.26-7.58 
 
0.21 
 
PaO2, 
mmHg 
28 97.3 ± 39.00 
 
34-243 
 
109.52 ± 35.59 
 
34-179 
 
0.12 
PaCO2, 
mmHg 
28 35.3 ± 10.08 
 
23-71 
 
35.44 ± 10.26 
 
18-69 
 
0.93 
 
Bicarbonate, 
mmol/L 
28 21.22 ± 6.05 
 
11-43 
 
21.96 ± 5.71 
 
12-42 
 
0.25 
 
SaO2, % 28 95.93 ± 3.66 87-100 97.67 ± 1.92 93-100 .02 
Serum 
glucose, 
mg/dl 
30 106.9 ± 17.81 77-155 121.10 ± 47.47 62-282 .12 
Serum 
sodium, 
mmol/L 
30 138.97 ± 5.54 
 
127-150 
 
139.03 ± 4.14 131-148 .93 
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Table 4.2 (Continued): Comparison of patient clinical data at baseline during MV 
and on the day of initial weaning trial  
Variable n Baseline MV Weaning day p 
Mean ± SD Range Mean  ± SD Range 
Serum 
potassium, 
mmol/L 
30 3.92 ± 0.61 
 
2.9-5.7 3.9 ± 0.65 3-6.2 .83 
Serum 
calcium, 
mg/dl 
30 7.56 ± 0.77 
 
5.3-9.3 7.89 ± 0.84 5.3-9.3 .02 
Serum 
magnesium, 
mg/dl 
19 1.83 ± 0.44 
 
1.3-3.6 2.02 ± 0.42 1.4-3.1 .007 
Serum 
phosphorus, 
mmol/L 
18 3.93 ± 1.97 
 
1.1-10.1 3.46 ± 1.18 1.9-6.2 .26 
Serum 
chloride, 
mmol/L 
29 109.68 ± 8.08 90-129 108 ± 7.21 91-120 .47 
Serum 
creatinine, 
mg/dL 
30 1.86 ± 2.05 .43-9.80 1.55 ± 1.25 .44-5.89 .14 
Blood urea 
nitrogen, 
mg/dL 
29 27.65 ± 28.02 5-138 27.17 ± 19.70 5-80 .41 
Serum 
albumin, g/L 
11 1.80 ± 0.50 .9-2.7 1.96 ± 0.59 1-3.8 .28 
Serum total 
bilirubin, 
g/dL 
11 
2.69 ± 1.82 .3- 7.6 2.15 ± 1.44 .4- 5 
.21 
White blood 
cells, K/uL 
30 14.6 ± 7.55 1.5-32 12.77 ± 5.53 3.5-23.9 .09 
Red blood 
cells, M/uL 
30 3.36 ± 0.54 2.05- 4.68 3.18 ± 0.30 2.64- 3,78 .04 
Platelets, 
K/uL 
30 180.07 ± 
114.22 34-483 
205.83 
±180.62 18-962 
.44 
Hemoglobin, 
g/L 
30 10.11 ± 1.68 6.9-14 9.60 ± 0.94 7.8-11.4 .05 
Hematocrit, 
% 
30 29.07 ± 4.75 20.3- 41.5 28.04 ± 2.64 24- 33.2 .05 
Cumulative 
fluid balance, 
mL 
30 12364.39 ± 
10558.67 
-1431.40- 
42406.00 
15340.06 ± 
13764.52 
-528.40- 
52804.00 
.03 
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Changes in Respiratory Mechanics 
In this study, 27 patients out of 30 were exposed to a combination of PS (8-15 cm 
H2O) and CPAP 5 cm H2O (PS+CPAP) during weaning trial. Three patients self- 
extubated and received supplemental oxygen through either a partial rebreathing or non-
rebreathing mask. 
Respiratory mechanics were measured at baseline during MV and during weaning 
trial. Respiratory rate (total and spontaneous), peak and mean airway pressures were 
significantly different from baseline values (Table 4.3). There was no differences in RSBI 
for patients who failed weaning (57.05± 36.25), and patients who had successful weaning 
trial (24.00± 7.94); t (21) = 1.54, p= .14.  
 
Table 4.3: Comparison of respiratory characteristics at baseline during MV and 
during the initial weaning trial  
Variable  n Baseline MV 
Mean± SD 
Weaning 
(PS+CPAP) 
Mean± SD 
P  
Vt, ml/min 25 526 ± 192.47 476.32 ± 151.26 .26 
FiO2, proportion of 1.0 29 0.47 ± 15.38 0.42 ± 12.22 .14 
Total RR, breaths/min 30 17.57 ± 4.85 21.73 ± 7.52 .01 
Spontaneous RR, 
breaths/min 
30 3.63 ± 5.68 21.73 ± 7.52 < 0.001 
PEEP, cm H2O 27 6.74 ± 4.71 5.00 ± 0.00 .06 
Airway pressure 
Peak 
Mean 
 
24 
24 
 
29.38 ± 8.88 
14.60 ± 9.17 
 
18.13 ± 6.40 
9.34 ± 3.20 
 
< 0.001 
.007 
Vt = Tidal volume; FiO2= Fraction of inspired oxygen; RR= respiratory rate; PEEP= 
Positive end-expiratory pressure. 
 
Changes in Cardiac Rhythm 
Cardiac rhythm data were collected at baseline for 24- hours. During the initial 
weaning trial, cardiac rhythm data were continuously recorded 1- hour before and during 
weaning trial up to 24 hours. For the purpose of this study, data of cardiac rhythm was 
reported for the first 2 hours after initiation of the first weaning trial. All subjects (n=35) 
had complete electrocardiographic data at baseline. Two data records obtained during 
weaning could not be analyzed because of high T wave amplitude. Electrocardiographic 
data during weaning were collected from 25 patients only because 3 patients died, 2 
patients had tracheostomy before weaning and 3 patients self extubated. In addition, 
 
42 
weaning trials for another 2 patients were missed by the investigator. One patient had a 
single episode of ventricular tachycardia during weaning; none had ventricular or atrial 
fibrillation. All patients experienced either ventricular or supraventricular ectopic beats or 
both. The mean supraventricular ectopic beats per hour during weaning was significantly 
higher than the mean at baseline; the mean of ventricular ectopic beats per hour did not 
change (Table 4.4).  
 
Table 4.4: Comparison of cardiac rhythm at baseline during MV and during the 
initial weaning trial (n=25) 
Cardiac Rhythm Baseline  
Mean ± SD 
Weaning  
Mean ± SD 
p  
Mean supraventricular beats/hour 40 ± 82.16 366± 1726.32 < 0.001  
Mean ventricular beats/hour 15 ± 37.4 14 ± 27.24 .68 
 
Comparisons of the mean of supraventricular ectopic betas at baseline and during 
weaning for all patients and per individual patients (n=25) are shown in Figures 4.1and 
4.2 respectively. Comparisons of the mean of ventricular ectopic betas per hour at 
baseline and during weaning for all patients and per individual patients (n=25) are shown 
in Figure 4.3 and 4.4 respectively. 
 
Figure 4.1: Comparison of mean supraventricular ectopic at baseline and during 
weaning for all patients (n=25) 
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Figure 4.2: Comparison of mean supraventricular ectopic at baseline and during 
weaning per individual patients (n=25) 
 
 
Figure 4.3: Comparison of mean ventricular ectopic at baseline and during weaning 
for all patients (n=25) 
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Figure 4.4: Comparison of mean ventricular ectopic at baseline and during weaning 
per individual patients (n=25) 
 
 
Changes in Heart Rate Variability (HRV) 
The 5-min segments in which 80% of R-R intervals were normal were analyzed 
for 22 patients at baseline during MV and during the initial weaning trial.  Out of the 22 
patients, 5 patients had a successful weaning trial and 17 patients failed the trial.  
Compared to baseline values, there were no changes in very low frequency (VLF) 
power and high-frequency (HF) power; but significant increases in low-frequency (LF) 
with exposure to PS + CPAP during weaning trial (p ≤ 0.05) as shown in Table 4.5.  
 
Table 4.5: Heart rate variability at baseline and during the initial weaning trial 
(n=22) 
Variable Baseline 
Mean± SD 
Weaning 
Mean± SD 
p 
VLF 79.41 ±  109.97 111.09 ± 139.64 .06 
LF 82.86 ±  126.43 202.62 ± 391.27 .04 
HF 78.84 ± 108.99 50.16 ± 71.85 .18 
VLF= Very low frequency; LF= Low-frequency; HF= High-frequency 
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Patients who had a successful weaning trial had no change in VLF, LF, and HF 
power (Table 4.6). Patients who had a failed weaning trial had significant increases in LF 
power and significant decreases in HF power (Table 4.7). 
 
Table 4.6: Heart rate variability of patients who had successful weaning trial at 
baseline and during weaning trial (n=5) 
 Baseline 
Mean ± SD 
Weaning 
Mean ± SD 
P 
VLF 105.56 ±  142.66 63.46 ± 57.88 .39 
LF 151.45 ± 221.09 109.98 ± 97.92 .62 
HF 55.1 ± 55.54 104.49 ± 137.13 .33 
VLF= Very low frequency; LF= Low-frequency; HF= High-frequency 
 
Table 4.7: Heart rate variability of patients who failed the initial weaning trial at 
baseline and during weaning trial (n=17) 
 Baseline  
Mean ± SD 
Weaning  
Mean ± SD 
P  
VLF 72.88 ± 103.76 122.99 ± 152.24 .06 
LF 66.96 ± 91.63 230.78 ± 433.92 .04 
HF 107.81± 141.15 45.30 ± 55.08 .04 
VLF= Very low frequency; LF= Low-frequency; HF= High-frequency 
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Comparisons of HRV at baseline and during weaning for the whole sample 
(n=22), and per individual patients are displayed in Figures 4.5 - 4.8. 
 
Figure 4.5: Comparison of heart rate variability at baseline and during weaning for 
all patients (n=22) 
 
 
Figure 4.6: Comparison of VLF at baseline and during weaning per individual 
patients (n=22) 
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Figure 4.7: Comparison of LF at baseline and during weaning per individual 
patients (n=22) 
 
 
Figure 4.8: Comparison of HF at baseline and during weaning per individual 
patients (n=22) 
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Relationship of heart rate variability (HRV) during weaning to the occurrence of 
cardiac dysrhythmias 
Multiple regression analyses were separately conducted to test the potential 
relationship between HRV and occurrence of ventricular and supraventricular ectopic 
beats during weaning. The ratio scores (i.e., average score at weaning divided by average 
score at baseline) of HF, LF, and VLF power were regressed separately on the mean 
number of ventricular and supraventricular ectopic beats during weaning after controlling 
for APACHE IV score on the day of weaning. In each hierarchical regression, APACHE 
IV score was entered first, and each of the HRV components was entered last in order to 
test their unique contribution to prediction. 
Multiple linear regression analysis revealed that HRV in the HF power 
significantly accounted for 68% of the variance in occurrence of ventricular ectopic beats 
(β = .79, p = < .001) and for 29% of the variance in occurrence of supraventricular 
ectopic beats during weaning (β = .53, p = .02) as shown in Tables 4.8 and 4.9 
respectively. VLF accounted for 63% of the variance in occurrence of ventricular ectopic 
(β = .776, p = < .001) as displayed in Table 4.10 VLF power was not found to explain a 
significant amount of the variance in supraventricular beats during weaning (Table 4.11). 
LF significantly accounted for 41% of the variance in occurrence of ventricular ectopic 
beats (β = .60, p = .002), and 36% of the variance in occurrence of supraventricular 
ectopic betas (β =.61, p = .002) during weaning (Tables 4.12 and 4.13). 
 
Table 4.8: Multiple regression analysis of relationship between HF and occurrence 
of ventricular ectopic beats during weaning (N=21)  
Predictor 
variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.056 .006 .056 1.13 1, 
19 
.302 .213 
Step 2 
HF ratio 
.684 .649 .628 35.80 1, 
18 
< .001 .793 
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; HF= High 
frequency 
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Table 4.9: Multiple regression analysis of relationship between HF and occurrence 
of supraventricular ectopic beats during weaning (N = 20) 
Predictor  
Variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.001 -.055 .001 .012 1, 18 .904 -.042 
Step 2 
HF ratio 
.285 .201 .285 6.78 1, 17 .02 .534 
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; HF= High 
frequency 
 
Table 4.10: Multiple regression analysis of relationship between VLF and 
occurrence of ventricular ectopic beats during weaning (N = 25) 
Predictor 
variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.056 .015 .056 1.365 1, 23 .255 .076 
Step 2 
VLF ratio 
.633 .599 .577 34.522 1, 22 < .001 .776 
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; VLF= Very low 
frequency 
 
Table 4.11: Multiple regression analysis of relationship between VLF and 
occurrence of supraventricular ectopic beats during weaning (N = 24) 
Predictor 
variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.001 -.045 .001 .015 1, 22 .904 -.252 
Step 2 
VLF ratio 
.020 -.073 .020 .418 1, 21 .525 .647 
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; VLF= Very low 
frequency 
 
Table 4.12: Multiple regression analysis of relationship between LF and occurrence 
of ventricular ectopic beats during weaning (N = 25)  
Predictor 
variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.056 .015 .056 1.365 1, 23 .255 .140 
Step 2 
LF ratio 
.406 .352 .350 12.96 1, 22 .002 .600 
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; LF= Low frequency
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Table 4.13: Multiple regression analysis of relationship between LF and occurrence 
of supraventricular ectopic beats during weaning (N = 25) 
Predictor 
variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.001 -.045 .001 .015 1, 22 .904 -.126 
Step 2 
LF ratio 
.360 .298 .359 11.750 1, 21 .002 .608 
APACHE IV= Acute Physiology and Chronic Health Evaluation IV; LF= Low frequency 
 
Relationship of the occurrence of dysrhythmias to length of mechanical ventilation  
Pearson correlation coefficients were computed among length of MV, APACHE 
IV score at weaning, rapid shallow breathing index (RSBI), cumulative fluid balance 
based on 24 hour intake and output, and PaO2/FiO2 (Table 4.14).  Length of MV was 
correlated significantly with APACHE score only (r = .369, p < .05). 
 
Table 4.14: Correlation between length of MV, APACHE score, RSBI, fluid status, 
and PaO2/FiO2 at weaning (n=25) 
 1 2 3 4 5 
1. Length of MV --- .369* .004 .296 -.019 
2. APACHE score  --- -.246 .077 .092 
3. RSBI   --- -.149 -.149 
4. Cumulative fluid balance    --- .077 
5. PaO2/FiO2 at weaning     --- 
MV = Mechanical ventilation; APACHE IV= Acute Physiology and Chronic Health 
Evaluation IV; RSBI= Rapid shallow breathing index 
*p < .05, two tailed 
 
The mean number of ventricular and supraventricular ectopic beats during 
weaning was regressed separately on the mean time the patient received MV after 
controlling for APACHE IV score on the day of weaning; results are displayed in Tables 
4.15 and 4.16.  
Multiple linear regression analysis revealed that the occurrence of 
supraventricular ectopic beats during weaning accounted for 18% of the variance of the 
time patient spent on MV (β = 2.3, p = .032) as shown in Table 4.15. The occurrence of 
ventricular ectopic beats during weaning did not explain a significant amount of the 
variance in time patient spent on MV (Table 14.16).  
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Table 4.15: Multiple regression analysis of relationship between occurrence of 
supraventricular ectopic beats during weaning and length of MV (N=24) 
Predictor 
variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.130 .090 .130 3.275 1, 22 .084 .863 
Step 2 
Mean number 
of SVE/hr  
.305 .239 .176 5.308 1, 21 .032 2.304 
MV = Mechanical ventilation; APACHE IV= Acute Physiology and Chronic Health 
Evaluation; SVE=Supraventricular Ectopic Beats 
 
Table 4.16: Multiple Regression Analysis of relationship between occurrence of 
ventricular ectopic beats during weaning and length of MV (N=26) 
Predictor 
variable 
R2 Adj 
R2   
R2 
change 
F 
change 
df Sig. F 
change 
Standardized 
ß 
Step 1 
APACHE IV  
.130 .094 .130 3.589 1, 24 .070 1.929 
Step 2 
Mean number 
of VE/hr  
.143 .069 .013 .350 1, 23 .560 .592 
MV = Mechanical ventilation; APACHE IV= Acute Physiology and Chronic Health 
Evaluation; VE= Ventricular Ectopic Beats 
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CHAPTER V: DISCUSSION 
Discussion of Findings 
These data supported the hypotheses that: 1) HRV measured in the frequency 
domain during weaning was related to the occurrence of cardiac dysrhythmias; and 2) 
rate of supraventricular ectopic beats per hour during weaning was an independent 
predictor of length of MV. 
Our study results showed that exposing patients (n=22) to a combination of PS10 
cm H2O and  CPAP 5 cm H2O during weaning generated a significant increase in LF 
power with no change in VLF or HF power compared to baseline.  Our study findings 
were in  partial disagreement with Frazier at al. 33 findings.  Frazier et al.33 reported a 
significant increase in VLF power and a significant decrease in HF power with exposure 
to a combination of PS 10 cm H2O and CPAP 10 cm H2O in a group of six anesthetized 
canines with normal ventricular function studied in a laboratory setting. The 
disagreement can be attributed to the underlying cardiac function of subjects enrolled in 
each study and the degree of positive ITP achieved during weaning. The use of 
PS+CPAP during weaning produces positive ITP. Positive ITP decreases the pressure 
gradient between the vena cava and right atrium, which in turn decreases venous return 
and RV preload. The higher level of positive ITP pressure achieved during weaning is 
accompanied by further reduction in RV preload in subjects with normal cardiac function 
as found by Frazier et al.33 As a result, the ANS compensated by increasing sympathetic 
tone (reflected by VLF power) and decreasing parasympathetic tone (reflected by HF 
power) 33 in order to maintain adequate cardiac output and oxygen delivery. The ANS 
adaptive response can be significantly altered in presence of impaired cardiac function as 
demonstrated by our findings. In our study, 49% of patients were known to have impaired 
cardiac conditions. The acute fluid shift during weaning can be challenging for these 
patients, which explains dominance of sympathetic tone activity in our study 
demonstrated by increased LF power. 
Although the potential anxiety and stress that patients experience during weaning 
from MV was not measured in this study or any previous published studies, stress and 
anxiety are known to further augment activation of sympathetic tone. The effect of 
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emotional stress was removed in Frazier et al. 33 study as their study was conducted in a 
controlled laboratory setting and the subjects were anaesthetized.  
In the current study, patients were separated into two groups based on initial 
weaning trial outcome. Patients who experienced a successful weaning trial (n=5) 
exhibited no change in VLF, LF, and HF power, while patients who failed the weaning 
trial (n=17) exhibited increases in LF power and decreases in HF power compared to 
baseline. Changes in HRV exhibited by the two groups were in partial agreement with 
Shen et al.34 findings. Shen et al.34 analyzed HRV for 24 patients during weaning from 
MV during the transition from pressure support ventilation (PSV) to SBT (using a T-
piece trial), and found a significant decrease in LF and HF in patients who failed a 
weaning trial (n=12), but not in the success group. Although Shen and associates study 
and our study were conducted in ICU settings, differences in HRV findings in patients 
who failed a weaning trial can be attributed mainly to differences in design of the studies 
and methodologic factors. Shen and associates started HRV measurement 10- minutes 
after transition from (PSV) to SBT (T-piece trial), excluded patients who had frequent 
cardiac arrhythmias (defined as > 10% of nonsinus beats), and excluded the 5-minute 
segment in which more than 90% of the R-R intervals were not normal-to-normal (N-N) 
intervals from analysis. In our study, HRV measurement started upon exposure to 
PS+CPAP trial, only patients with atrial fibrillation/ flutter at baseline were excluded, 
and the entire 5-minute segment in which more than 80% of the R-R intervals were not 
normal-to-normal (N-N) intervals were excluded from analysis. In addition, patients 
enrolled in Shen and associates study were older than patients in our study (69.8 ± 17.8) 
vs. (53.3 ±14.6). Older age can explain the decrease in ANS adaptive response and the 
decrease in HRV measurements in Shen and associates study.143 Medications and 
underlying disease can have an impact on HRV analysis. However, these two factors 
were not evaluated in either study. 
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Changes in HRV that occurred during weaning may have influenced the 
occurrence of cardiac dysrhythmias, especially in patients with underlying cardiac 
dysfunction. Numerous studies have reported a significant relationship between reduced 
HRV and the genesis of malignant ventricular dysrhythmias, primarily ventricular 
fibrillation and ventricular tachyarrhythmias, especially in patients with heart failure, 
myocardial ischemia, and myocardial infarction. 35, 41, 42, 45, 101  
Several studies have shown imbalances that included increased sympathetic 
activity or decreased parasympathetic activity or both before occurrence of paroxysmal 
atrial fibrillation 36, 102 and atrial flutter104 in patients with underlying heart diseases. 
Huikur i et al.103 reported a significant decrease in HF power one hour before occurrence 
of ventricular tachycardia in patients with ischemic heart disease. Fei et al.38 reported 
significant changes in HRV immediately prior to the occurrence of tachyarrhythmias in 
patients with congestive heart failure. Fei et al.39 reported a significant increase in the 
LF/HF ratio immediately before occurrence of idiopathic VT episodes. Also, Hayashi et 
al.40 reported an increase in the LF/HF before the onset of ventricular tachycardia.  Our 
findings were in agreement with previous published literature. In our study, 49% of 
patients were known to have cardiac conditions. Increased sympathetic activity (reflected 
by increased LF power) was found to be arrhythmogenic. The LF power significantly 
predicted the occurrence of both ventricular and supraventricular ectopic beats during 
weaning. Although HF and VLF power did not change during weaning compared to 
baseline, multiple regression analyses showed that HF power measured during weaning 
was a significant predictor of occurrence of ventricular and supraventricular ectopic beats 
during weaning; and VLF power measured during weaning was found to be a significant 
predictor of the occurrence of ventricular ectopic beats but not of occurrence of 
supraventricular beats during weaning.  
All patients in this study demonstrated either ventricular or supraventricular 
ectopic beats or both during weaning. The mean supraventricular ectopic beats per hour 
during weaning were double the mean at baseline, while the mean of ventricular ectopic 
beats per hour did not change. Frazier et al.17 reported that the number of supraventricular 
ectopic beats per hour during weaning was almost double the number at baseline, and the 
number of ventricular ectopic beats per hour decreased by nearly two thirds during 
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weaning in 39 patients exposed to CPAP during weaning attempts. Thus, our results 
mirrored the change in SVEs, but not VEs. This can be attributed to the degree of positive 
ITP achieved during weaning and data measurements points of time. In our study, we 
measured cardiac rhythm for 24- hours at baseline and for the first 2-hour after exposing 
the patients to a combination of PS (8-15 cm H2O) and CPAP 5 cm H2O during weaning 
trial. Frazier and associates measured cardiac rhythm for 24- hours at baseline; 1-hour 
before, during, and up to 24 hours after exposing patients to a combination of PS10 cm 
H2O and CPAP 10 cm H2O. The higher the positive ITP applied during weaning, the 
greater is the impact on acute fluid shift into the intrathoracic vascular component, ANS 
activity and in turn the greater is the negative effects on myocardial action potential. The 
underlying disease process of enrolled patients may have an impact on occurrence of 
ventricular and supraventricular ectopic beats. In our study, the heterogeneous patient 
population was recruited from MICU, CCU, TICU, CTICU and NICU, while Frazier and 
associates enrolled a homogeneous patient population from MICU only. Finally, patients 
enrolled in both studies were critically ill. These patients were subjected to a wide variety 
of procedures at baseline and during weaning that have varied impact on the occurrence 
of cardiac dysrhythmias.  
In this study, we hypothesized that cardiac dysrhythmias would contribute to 
difficulty with weaning from MV and thus increase the length of time required for MV.   
Multiple linear regression analyses revealed that the occurrence of supraventricular, but 
not ventricular ectopic beats during weaning was a significant predictor of length of MV. 
This study was the first to evaluate the impact of occurrence of cardiac dysrhythmias 
during weaning on length of MV. These results advance our understanding of the 
negative impact of cardiac dysrhythmias on cardiac contractility and myocardial oxygen 
demand, and in turn weaning outcome. Therefore, cardiac rhythm should be 
systematically evaluated during MV and weaning in order to decrease length of MV. 
Study Limitations 
There are some limitations to this study. First, the sample size is small and that 
may affect the power of the study to detect differences. Larger sample sizes are 
recommended for future studies. Second, we did not collect other biomarkers of 
autonomic activity, such as plasma catecholamine levels and baroreflex sensitivity. 
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However, power spectral analysis of HRV is a valid and reliable noninvasive indicator of 
autonomic nervous system modulation activity. Third, in this study, a heterogeneous 
patient population with various underlying diseases was included, which might have had 
considerable effects on the length of MV. The reason of enrolling a heterogeneous patient 
population was to mirror the actual patient population found in intensive care units, in 
order to generalize the study findings to include patients with different underlying disease 
processes. Fourth, the majority of patients were male (67%) and Caucasian (97%), which 
may affect the generalizability of the study findings. Enrolling patients with approximate 
numbers of both genders and different categories of ethnicity is recommended for future 
studies. Fifth, according to the routine care followed in the proposed clinical area, the 
process of weaning starts once the physician prescribes weaning. This resulted in the PI 
missing the initial weaning trial for two patients. Sixth, the design of this study is a 
repeated measures design. So, death or tracheostomy events that occurred before the first 
weaning trial limited the number of patients with complete data for the two time periods. 
Therefore, a larger sample size is recommended for future studies.  
SUMMARY AND CONCLUSION 
In summary, this study was the first to investigate the relationship of the 
occurrence of cardiac dysrhythmias during weaning to the length of MV. We 
demonstrated that changes in HRV measured during weaning significantly predicted the 
occurrence of cardiac dysrhythmias during weaning and the occurrence of 
supraventricular ectopic beats during weaning was a significant predictor of the length of 
MV.  Early detection of ANS alterations and effective management of cardiac 
dysrhythmias during weaning is of paramount importance because these alterations can 
contribute to longer MV time.  
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APPEDICES 
Appendix A: Institutional Review Board 
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Appendix B: Data collection instrument 
Socio-demographic characteristics and clinical data collection instrument 
ID#      Date of data collection 
Date hospital admission     Unit  
Date of ICU admission      
Part 1: SOCIODEMOGRAPHIC CHARACTERISTICS 
1. Sex: 0.______ Male 1.______ Female 
2. Age ____ Years old_____ 
3. Marital Status:  0._____ Single  
  1._____ Married 
  2._____ Divorced/Separated 
 3._____ Widowed 
 4._____ Co-habitate (living with a good friend or partner) 
4. Type of insurance: 1. Government insurance (Medicare, Medicaid, or military 
medical)  
2. Commercial insurance (fee-for service and PPO carriers) 
3. HMO (health maintenance organization characterized by 
coverage that provides healthcare services for members on a 
prepaid basis). 
4. None or self 
5. Ethnicity: 1. _____ Black or African-American (not Hispanic or Latino) 
  2. _____ White or Caucasian (not Hispanic or Latino)  
  3. _____ Asian 
  4. _____ Hispanic or Latino   
  5. _____ American Indian or Alaskan Native 
  6. _____ Native Hawaiian or other Pacific Islander 
  7. _____ Other (please specify______________________________) 
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6. What is the highest level of education the patient have completed? 
1. _______ Less than high school graduate 
2. _______ High school graduate 
3. _______ some post high school 
4. _______ Some college  
5. _______ Associate degree 
6. _______ Bachelor’s degree 
7. _______ Master’s degree 
8. _______ Professional degree 
9. _______ Doctoral degree 
7. Patient’s Height _________________________, body weight _____________lbs 
8. Hospital length of stay prior to ICU admission                                       days. 
9. Hospital length of stay prior to ICU intubation                                       days. 
10. Functional limitation prior to admission 0.______ No 1.______Yes. 
 If yes, describe  
11. Regular medications prior to admission ______________________________ 
12. Does the patient have any previous history of mechanical ventilation? 
 0.______ No 1.______Yes 
 If yes, a- When? 
b- Specify the cause  
 c- Length of previous mechanical ventilation _____________ days/hours 
 d- Complications during previous mechanical ventilation period  
13. Does the patient have any history of cardiac rhythm disturbances?  
 0.______ No 1.______Yes 
If yes, a- Specify  
b- For how long?     days 
 c- What medication used for its management?  
14. Medical diagnoses upon admission:  
15. Reason for current mechanical ventilation: 
 1. Airway protection 2. Excessive work of breathing 
 3. Inadequate oxygenation 4. Hypercapnia 
5. Other (please specify)  
16. Length of current MV prior to beginning the study: _____________days/hours 
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17. APACHE III score    
Part 2-I: Clinical Data (Baseline) ID#  
Day #     Date  
Physiological Status  WBC / RBC  Cdyne / Cst  
GCS  Platelets  Airway resistance  
Patient temperature  Hemoglobin   WOBv  /  WOBp  
arterial pH    Hematocrit  P O.1  
PaCO2  Pulmonary Status  Ti / Ttot (cycle time)  
PaO2  Ventilator mode  Peak airway / Mean 
airway pressures 
 
HCO3  E.T.T size/location  RSBI   
SaO2  Set ventilator rate   PaO2/FiO2  
SpO2  Total rate  Self extubation 
incidence 
 
Glucose / Hgb A1C  Spontaneous RR  Re-intubation  
BUN  Vt I( Set) / Vt 
( returned) 
 Cardiovascular  
 Status 
 
Creatinine   Spontaneous Vt 
exhaled 
 Systolic BP   
Sodium  Pressure control set 
above PEEP  
 Diastolic BP  
Potassium  Pressure support   Mean arterial 
pressure 
 
Chloride  PEEP level  HR  
CO2  CPAP level  CVP  
Calcium(tot)/Ionized  FiO2  I&O Status  
Bilirubin  Minute Vent total   Total 24 hour intake  
Albumin  Minute Vent expired   Total 24 hour output  
Magnesium  Minute Vent 
inspired 
 Cumulative Intake  
Cumulative Output  
Phosphorous  Minute Vent esp  Cumulative fluid 
balance 
 
 
Date and description of 12 lead EKGs 
 
Date and description of CXRs 
 
Date and description of cardiac cath/echo 
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Current medications and dosages 
Prescribed Drug 
Name 
Dose/Route/Frequency/Dates of 
Administration 
Comments (Total Dose 
per 24 hours) 
   
   
   
   
 
Part 3: Events summary and patients disposition 
 
1. Total length of stay: Hospital   ICU 
2. Total # ventilator ________  days _____________ hours. 
3. Number of weaning trials 
4. a. Initial weaning trial date and time _____________ 
 b. Mode of weaning _____________ 
 c. Length of weaning trial _____________ 
d. Weaning outcome: success                    Failure  
5. If failed weaning trial, reasons identified in the patient medical record 
6. Tracheostomy:  Yes  No  
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